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ABSTRACT 
Aims: Traditional medicinal use of species of the genus Drypetes is widespread in the tropical regions. 
The aim of this review is to systematically appraise the literature available to date on phytochemistry, 
ethnopharmacology, toxicology and bioactivity (in vitro and in vivo) of crude extracts and purified 
compounds.  
Ethnopharmacological relevance: Plants of the genus Drypetes (Putranjivaceae) are used in the 
Subsaharan African and Asian traditional medicines to treat a multitude of disorders, like dysentery, 
gonorrhoea, malaria, rheumatism, sinusitis, tumours, as well as for the treatment of wounds, 
headache, urethral problems, fever in young children, typhoid and several other ailments. Some 
Drypetes species are used to protect food against pests, as an aphrodisiac, a stimulant/depressant, a 
rodenticide and a fish poison, against insect bites, to induce conception and for general healing. This 
review deals with updated information on the ethnobotany, phytochemistry, and biological activities 
of ethnomedicinally important Drypetes species, in order to provide an input for the future research 
opportunities. 
Methods: An extensive review of the literature available in various recognized databases e.g., Google 
Scholar, PubMed, Science Direct, SciFinder, Web of Science, www.theplantlist.org and 
www.gbif.org, as well as the Herbier National du Cameroun (Yaoundé) and Botanic Gardens of 
Limbe databases on the uses and bioactivity of various species of the Drypetes was undertaken. 
Results: The literature provided information on ethnopharmacological uses of the Subsaharan African 
and Asian species of the genus Drypetes, e.g., Drypetes aubrévillii, D. capillipes, D. chevalieri, D. 
gerrardii, D. gossweileri, D. ivorensis, D. klainei, D. natalensis, D. pellegrini (all endemic to Africa) 
and D. roxburghii (Asian species), for the treatment of multiple disorders. From a total of 19 species, 
more than 140 compounds including diterpenes, sesquiterpenes, triterpenes (friedelane, oleanane, 
lupane and hopane-type), flavonoids, lignans, phenylpropanoids and steroids, as well as some 
thiocyanates, were isolated. Several crude extracts of these plants, and isolated compounds displayed 
significant analgesic, anthelmintic, antidiabetic, anti-emetic anti-inflammatory, antioxidant, 
antiparasitic, central nervous system depressant, cytotoxic, and insecticidal activities both in vitro and 
in vivo. Some toxicities associated with the stem, bark, seed and leaf extracts of D. roxburghii, and 
the flavonoid, amentoflavone, isolated from the stem extract of D. littoralis as well as D. gerrardii, 
were confirmed in the animal models and in the rat skeletal myoblast cells assays. As a consequence, 
traditional medicine from this genus should in future be applied with care.  
Conclusions: Plants of this genus have offered bioactive samples, both from crude extracts and pure 
compounds, partly validating their effectivity in traditional medicine. However, most of the available 
scientific litteratures lacks information on relevant doses, duration of the treatment, storage conditions 
and positive controls for examining bioefficacy of extract and its active compounds. Additional 
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toxicological studies on the species used in local pharmacopeia are urgently needed to guarantee safe 
application due to higth toxicity of some crude extracts. Interestingly, this review also reports 10 
pimarane dinorditerpenoids structures with the aromatic ring C, isolated from the species collected in 
Asia Drypetes littoralis (Taiwan), D. perreticulata (China), and in Africa D. gerrardii (Kenya), D. 
gossweileri (Cameroon). These compounds might turn out to be good candidates for chemotaxonomic 
markers of the genus. 
 
Keywords: Drypetes, Ethnopharmacology, Chemical constituents, Bioactivities 
 
1. Introduction 
The genus Drypetes, previously put in Euphorbiaceae family, has been included within the  
Putranjivaceae based partly on the presence of the mustard oils in their leaf tissus, a compound they 
share with the genus Putranjiva in this family and because its was the sole pantropical zoochorous 
genus of the Euphorbiaceae. The Putranjivaceae was formerly a tribe (Drypeteae) of the subfamily 
Phyllanthoideae in the Euphorbiaceae. When the Phyllanthoideae was separated to form the new 
family Phyllanthoideae, it was decided that Drypeteae also could stand alone (APG III, 2009). The 
greatest diversity of the genus Drypetes is found in Asia, with about 120 known/documented species. 
Approximately 75 species grow in Africa and Madagascar, with around 20 species, many of them as 
yet unexplored, found in the Americas. Most species are narrowly distributed, but D. roxburghii is 
found in seasonal forests from Pakistan to Indonesia (Levin, 2014). Plants of the genus Drypetes are 
trees or shrubs, with alternate, coriaceous or chartaceous and entire or toothed leaves; stipules are 
caducous and rarely persistent. Pedicellate male and female flowers are arranged in bundles in the 
axils of the leaves, or are produced on older branches or the stem. Flowers of this genus are dioecious 
and petals absent: male flowers have globose buds, and four or five broad, imbricate, usually 
coraceous septals. Typically, three or more stamens are inserted around and at the base of a central 
flat concave or occasionally cupular disk, and filaments are free. Anthers are erect and often large 
with parallel cells dehiscing longitudinally, and a rudimentary ovary is either absent or represented 
by a small conical protrusion in the middle of the disk. In common with the male flower the female 
version display a calyx, with a hypnogynous annular or cupular disk. The ovary has between one and 
four cells with 2 ovules in each cell; styles are short or absent and stigmas thick, flattened, bifid or 
undivided and more or less reniform. Fruits are globose, ellipsoid or ovoid and indehiscent with a 
thick, woody pericarp surrounding a solitary seed (by abortion) with fleshy albumen displays 1-4 
cells. The embryo is straight with flat, broad cotyledons (Baker, 1913). 
The classification developed by Pax and Hoffmann in 1922, although still valid today, is not 
completely congruent with postulated phylogenetic (Fig. 1) and evolutionary relationships (Wurdack 
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et al., 2004, Levin, 2014). For example, Drypetes roxburghii (Wall.) Hurus. (Synonym: Putranjiva 
roxburghii Wall.) is the accepted name. Thus, this review aims to present a synopsis on the 
ethnopharmacological uses and more than 140 secondary metabolites produced by the members of 
the Drypetes genus. In addition, bioactivities of assayed extracts and chemical constituents are also 
presented. 
 
Figure 1: Drypetes and Putranjiva clades within the subfamily Phyllanthoideae (shaded tree), 
family Euphorbiaceae (shaded column), “group“ Putranjivaceae: Molecular phylogenetic 
analysis using plastid rbcL DNA sequences (Wurdack et al., 2004). 
 
2. Materials and methods 
 
In order to assess the uses, chemical constituents and bioactivities of the crude extract as well as 
isolated compounds from the genus Drypetes, a wide range of literature sources were interogated (e.g. 
Google Scholar, PubMed, Science Direct, SciFinder, Web of Science, as well as the Herbier National 
du Cameroun (Yaoundé) and Botanic Gardens of Limbe databases). Critical reviews of plant 
taxonomy were sourced from www.theplantlist.org and plant occurrence from www.gbif.org. 
Relevant bibliographic items were identified systematically in the relevant libraries by searching for 
key terms including Drypetes, ethnobotany, ethnopharmacology, medicinal plants, chemical 
constituents, etc. Initially other terms were considered such as natural products, pharmacognosy, folk 
medicine and botany, but then excluded since their use did not result in relevant references. Four 
libraries with holdings both on useful/medicinal plants/pharmacognosy and the history of 
medicine/pharmacy were selected: Le Museum National d’Histoire Naturelle de Paris, The School of 
Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Herbier National du 
Cameroun, Yaoundé and Botanic Gardens of Limbe, Cameroon. These libraries contain relevant 
literature, which span a wide time period and most importantly cover the period prior to the 
introduction of electronic databases. The books chosen were searched for relevant information. Most 
but not all sources are written in English.  
3. Results and discussion 
3.1. Traditional medicinal use of species of the Drypetes genus 
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Various species of the genus Drypetes are narrowly distruibuted in tropical forested areas of Asia and 
utilised in a range of mostly unreported traditional medicinal applications. D. roxburghii, however, 
has wide ranging traditional medicinal applications for its fruits, seeds and leaves from Pakistan to 
Indonesia. This species is also found in the tropical Americas, and was introduced to Subsaharan 
Africa decades ago for medicinal purposes. In Subsaharan Africa, nine Drypetes species are used in 
traditional medicines, with the bark having multiple, prominent medical uses. Ethnopharmcological 
information on the Drypetes genus goes back to data collected from African species by Ainslie (1937), 
Bouquet (1969), Bouquet and Debray (1974), Burkill (1985), Cooper and Record (1931), Dalziel and 
Hutchinson (1937), Kerharo and Bouquet (1950), and Rapoda-Walker and Sillans (1961). Further 
ethnomedicinal knowledge on African and Asian species has been added by natural products chemists 
in the course of chemical and pharmacological investigations (table 1). 
 
Table 1. Ethnomedicinal uses of the species of the Drypetes genus 
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Name of species Country/Province Ethnomedicinal uses Type of recipe References 
 
 
 
 
 
D. aubrévillei 
Leandri 
Guinea, Liberia, Ghana 
and Ivory Coast 
Healing on the skin and 
mucosa 
Bark and fruit  
 
Burkill (1985) Pulmonary disorders and 
analgesic  
Bark 
Antipyretic Unspecified parts 
 
Liberia 
Fever, rheumatism and general 
fatigue 
Decoction of 
macerated bark and 
fruit 
 
Cooper and Record 
(1931) 
 
Elsewhere 
Blotchy skin, locally as 
“dishcloth” 
Powdered stem bark 
Expectorant and bronchial 
decongestant  
Pap made from the 
bark 
Bouquet and Debray 
(1974) 
 
 
Drypetes capillipes 
(Pax) Pax & K. 
Hoffm. 
Central African 
countries 
General analgesia Leaves and bark Burkill (1985) 
 
 
Congo (Brazzaville) 
Mouth-wash for severe 
toothache, and an enema for 
kidney-pains 
Bark decoction  
 
Bouquet (1969) 
Topical massage for stiffness 
of the neck 
Leaves 
 
 
 
 
 
 
Drypetes chevalieri 
Beille ex Hutch. & 
Dalziel 
 
Cameroon 
Tumours, swellings, 
inflammation and gonorrhoea  
Whole plant Dalziel and Hutchinson, 
(1937); Bouquet and 
Debray (1974) 
 
‘Kru’ and the Guere of 
Liberia  
 
Dysentery 
Sap expressed from 
leaves and twigs  
 
 
 
Kerharo and Bouquet 
(1950) 
Ivory Coast head-colds and sinusitis Powdered leaves 
 
 
 
West tropical Africa 
Intestines; pulmonary troubles 
and naso-pharyngeal affections 
 
 Leaves 
 
 
Burkill (1985) 
 Diarrhoea and dysentery Sap expressed from 
leaves and twigs  
Drypetes gerrardii 
Hutch 
Coast province, Kenya Malaria and other ailments Unspecified parts Ng′ang′ a et al. (2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drypetes 
gossweileri S. 
Moore; synonym: 
D. armoracia Pax 
& K. Hoffm. 
Democratic Republic of 
Congo, Gabon, 
Equatorial Guinea, 
Central African 
Republic and Cameroon 
General  healing Roots  
 
 
Burkill (1985) 
Analgesia, vermifuge, genital 
stimulant/depressant, against 
veneral diseases, as febrifuge, 
reptile-repellent, and as fish-
poison 
 
 
Bark 
Western Cameroon gonorrhoea and toothache  Bark Dalziel and Hutchinson, 
(1937) 
 
 
Central African 
Republic 
Helminthic diseases, 
rheumatism, fever and malaria 
Unspecified parts Ngoupayou et al. (2003); 
Tchinda and Sob, (2008); 
Raponda-Walker and 
Sillans (1961) 
Poison fishing  Bark and fruit Raponda-Walker and 
Sillans (1961) 
 
 
 
 
Gabon 
Anthelminthic Bark-macerate or 
decoction with 
pepper 
 
 
 
Bouquet (1969);  
Akendengue and Louis 
(1994) 
Rheumatism, headaches, 
general pain, body-pains, 
helminths and filariasis  
Bark 
Wounds and for toothache  Roots  Troupin (1982) 
Poison fishing  Bark and fruit Raponda-Walker and 
Sillans (1961) 
 
 
 
 
 
 
Congo (Brazzaville) 
Vermifugal enema  Bark-macerate or 
decoction with 
pepper 
 
 
 
 
Bouquet (1969) 
Urethral discharge or as an 
aphrodisiac 
Bark powder is 
cooked together with 
bananas 
Fever in young children Powder-decoction is 
added to bath water 
Repel snakes Boiled bark water 
Antipyretic, analgesic, 
aphrodisiac, for body pain, 
headache and urethral 
problems 
Bark 
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An overview on, the occurrence and traditional use of this plants is presented below. 
3.1.1. Drypetes aubrévillei Leandri 
Drypetes aubrévillei Leandri (locally called “Duamoko” in West African countries) grows in the West 
African countries of Guinea, Liberia, Ghana and Ivory Coast. The bark and fruit are used for general 
healing on the skin and mucosa, while the bark alone is utilised for pulmonary disorders and analgesic 
applications. Unspecified parts of the plant are also used as a febrifuge (antipyretic) (Burkill, 1985). 
In Liberia, a decoction of macerated bark and fruit is used as a liniment for application in fever, 
Nkundo region of 
Congo 
Back pain, insect bites, and 
dental caries 
Bark shavings 
rubbed onto skin 
Otitis Stem bark juice Muganza et al. (2012) 
 
Nigeria 
 
Deep wounds  
Roots are powdered 
with kola and Celtis 
integrifolia 
 
Ainslie (1937) 
Central African 
Republic 
Protect food against pests Bark Aba et al. (2013); Motte, 
(1980) 
Fever, malaria and typhoid  Bark Kajode et al. (2008). 
 
 
Drypetes ivorensis 
Hutch. & Dalziel 
Liberia, Cameroon, 
Ghana, Ivory Coast, and 
Gabon 
Skin and mucosa treatments;  
rodenticide, mammal and bird 
poison 
Bark and fruit Burkill (1985) 
 
 
 Ivory Coast 
Dressings to mature boils and 
carbuncles. 
Poison bait for rats, mice and 
other noxious animals 
Bark Kerharo and Bouquet 
(1950); Bouquet and 
Debray (1974) 
 
 
Drypetes klainei 
Pierre ex Pax 
Central African 
Republic 
Analgesic, vermifuge and  fish 
poison  
fruit Raponda-Walker and 
Sillans (1961); Burkill 
(1985) 
 
Gabon 
Rheumatism, and 
anthelminthic  
 
Macerate or 
decoction of fresh 
bark 
Raponda-Walker and 
Sillans (1961); 
Drypetes natalensis 
(Harv.) Hutch 
Tanzania Malaria and other ailments  Unspecified parts Gessler et al. (1995) 
Drypetes pellegrini 
Leandri 
Ivory Coast Ivorian multi-purpose 
medicine  
Bark Aubréville (1959) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drypetes 
roxburghii (Wall) 
Hurus 
 
 
 
 
 
 
 
 
 
 
 
 
 
India 
Catarrh, skin disease, fever, 
cold, rheumatism, 
inflammation, sterility, as 
aphrodisiac, a tonic to aid 
conception, muscle twisting, 
arthralgia and for of filarial 
diseases  
Leaves, fruit and 
seeds 
Chopra et al. (1970b); 
Kumar (2014c); Shahwar 
et al. (2012); Sudharshan 
et al. (2009); Thakur 
2011 
Insect bites Crushed seeds Kumar et al. (1998) 
spread on the maternity room 
floor for an easy delivery 
Scattered leaves  
worn to protect from red 
pimples and allergy  
Garland of its dried 
seeds 
Singh and Bisht (1999) 
Dysentery, fever, viral fever, 
spermopoietic, optic lavage to 
wash infected eyes, laxative, 
elephantiasis and sterility 
Leaf sap Singh et al. (2010); 
Kumar and Chaturvedi 
2010; Singh and Dubey 
(2012) 
Cold, fever, rheumatism and 
swollen throat  
Decoction of leaves 
and the bark 
 
Pandey and Tripati 
(2011); Maurya and 
Dongarwar 2012; Sharma 
and Bhadange (2013); 
Sreeramulu et al. (2013) 
Pain and aid conception A paste composed of 
the seeds; A leaf 
poultice along with 
the leaves of 
Dalbergia sissoo and 
Vitex negundo 
 
 
Kumar (2012). 
Bangladesh Curative properties and 
cardiovascular diseases 
Unspecified parts Mollik et al. 2(009). 
Gastrointestinal disorders 250 mg of powdered 
seeds are taken every 
4 h with a little sugar 
and water 
Kadir et al. (2013) 
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rheumatism and general fatigue; elsewhere, powdered stem bark is applied to treat a blotchy skin 
condition referred to locally as “dishcloth” (Cooper and Record, 1931). Pap made from the bark is 
also used as an expectorant and bronchial decongestant (Bouquet and Debray, 1974).  
3.1.2. Drypetes capillipes (Pax) Pax & K. Hoffm. 
Drypetes capillipes (Pax) Pax & K. Hoffm. (locally called “mò.kàmá” in Central African countries, 
and “gbólóga” by Baka Pygmies) grows in the Central African countries, Democratic Republic of 
Congo, Cameroon, Gabon, Equatorial Guinea and Central African Republic. The leaves and bark are 
widely used for general analgesia (Burkill, 1985). In Congo (Brazzaville), a bark decoction is used 
as a mouth-wash for severe toothache, and an enema for kidney-pains, while the leaves are applied 
in topical massage for stiffness of the neck (Bouquet, 1969). 
3.1.3. Drypetes chevalieri Beille ex Hutch. & Dalziel 
Drypetes chevalieri Beille ex Hutch. & Dalziel (locally called in Nigeria, “sunsun-iro” or “aya” by 
Yoruba and “owe” or “aghedan” by Edo) is found in Ivory Coast, Liberia, Gabon, Cameroon, Central 
African Republic, Ghana, Equatorial Guinea and The Democratic Republic of Congo. In Cameroon, 
the plant is used locally for the treatment of tumours, swellings, inflammation and gonorrhoea 
(Dalziel and Hutchinson, 1937; Bouquet and Debray, 1974). Sap expressed from leaves and twigs is 
taken in draught by the ‘Kru’ and the Guere of Liberia for dysentery, and the powdered leaves are 
sometimes used in Ivory Coast as a snuff for head-colds and sinusitis (Kerharo and Bouquet, 1950). 
The leaf is used in west tropical Africa for "intestines"; pulmonary troubles and naso-pharyngeal 
affections, while the sap is used against diarrhoea and dysentery (Burkill, 1985). 
3.1.4. Drypetes gerrardii Hutch; synonym: Drypetes gerrardii var. gerrardii 
Drypetes gerrardii Hutch (locally called “Itulelei tree” in Kenya) grows in Kenya, United Republic 
of Tanzania, Malawi, South Africa, Mozambique, Uganda and Swaziland, and is reported to be used 
to treat malaria and other ailments among 'Chonyi' people in Kilifi District, Coast province, Kenya 
(Ng′ang′ a et al., 2011).  
3.1.5. Drypetes gossweileri S. Moore; synonym: D. armoracia Pax & K. Hoffm. 
Drypetes gossweileri S. Moore (locally called “horseradish tree” in English; “bologa” or “kode” or 
“olelang” in Cameroon; “gama”or “n´zongo” or “ngama” in Central African Republic; “bonsole”, 
“boshimi” or “muyuyungu” or “pilipili” or “vungu” or “yungu” in Congo; “akot” or “ossôgho” in 
Gabon; “agawo” or “okhuaba” in Nigeria) is found in the Democratic Republic of Congo, Gabon, 
Equatorial Guinea, Central African Republic and Cameroon. While the root is applied for general 
healing, the bark is used for analgesia, vermifuge, genital stimulant/depressant, against veneral 
diseases, as febrifuge, reptile-repellent, and as fish-poison (Burkill, 1985). In Western Cameroon, the 
bark is adminstered for the treatment of gonorrhoea and toothache (Dalziel and Hutchinson, 1937), 
while unspecified parts of the plant are also used in the Central African Republic against helminthic 
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diseases, rheumatism, fever and malaria (Ngoupayou, 2003, Tchinda and Sob, 2008, Raponda-Walker 
and Sillans, 1961). Bark and fruit are used for poison fishing (Raponda-Walker and Sillans, 1961). 
Furthermore, a bark-macerate or decoction with pepper is used in Gabon as an anthelminthic, and in 
Congo (Brazzaville) as a vermifugal enema (Bouquet, 1969). In addition, the bark is used in the 
treatment of rheumatism, headaches, general pain, body-pains, helminths and filariasis in Gabon 
(Raponda-Walker and Sillans, 1961; Bouquet, 1969; Akendengue and Louis, 1994), whereas the roots 
are applied to wounds and for toothache (Troupin, 1982). In Congo, the bark powder is cooked 
together with bananas and taken to relieve urethral discharge or as an aphrodisiac, while a powder-
decoction is added to bath water for the relief od fever in young children. The bark is also reported to 
repel snakes, if a piece is kept in the hut-roof, or boiled bark water is sprinkled around the perimeter 
of the hut (Bouquet, 1969). In the Nkundo region of Congo bark shavings are rubbed onto skin for 
the treatment of rib or back pain, insect bites, and is also placed under the affected tooth in the case 
of dental caries. Stem bark juice is administered otically against otitis (Muganza et al., 2012), and 
certain populations in Congo use bark preparations as an antipyretic, analgesic and aphrodisiac, for 
body pain, headache and urethral problems, respectively (Bouquet, 1969). Bark and fruit are used as 
fish-poison in Gabon (Raponda-Walker and Sillans, 1961), and in Nigeria, the roots are powdered 
with kola and Celtis integrifolia to treat deep wounds (Ainslie, 1937). Like in Gabon, the bark is used 
by the Aka pygmies and the Monzombo people in the Central African Republic for poison fishing, 
and the plant is also used in the Boukoko area during postharvest to protect food against pests (Aba 
et al., 2013, Motte, 1980). Finally, medicines from the bark are prepared by local people in Osun 
State for the treatment of fever, malaria and typhoid (Kajode et al., 2008).  
3.1.6. Drypetes ivorensis Hutch. & Dalziel; synonym: Drypetes pierreana A. Chev. 
Drypetes ivorensis Hutch. & Dalziel (locally called “Kpahn-wee”) grows in Liberia, Cameroon, 
Ghana, Ivory Coast, and Gabon. The bark and fruit are used in skin and mucosa treatments, while the 
bark is additionally applied as a rodenticide, mammal and bird poison (Burkill, 1985). Furthermore, 
bark and fruit are used to prepare dressings to mature boils and carbuncles. The bark is considered 
toxic in Ivory Coast, and is used by the Akye to prepare poison bait for rats, mice and other noxious 
animals (Kerharo and Bouquet, 1950; Bouquet and Debray, 1974). 
3.1.7. Drypetes klainei Pierre ex Pax 
Drypetes klainei Pierre ex Pax (locally called “zogre or rokobasoki or rokobasole”) grows in Liberia, 
Cameroon, The Democratic Republic of Congo, Central African Republic, and Gabon. The bark of 
this plant is widely used as an analgesic and vermifuge, and together with the fruit as a fish poison 
(Raponda-Walker and Sillans, 1961; Burkill, 1985). In Gabon, a macerate or decoction of fresh bark 
is applied topically for treatment of rheumatism, and with a piment internally as an anthelminthic 
(Raponda-Walker and Sillans, 1961). 
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3.1.8. Drypetes natalensis (Harv.) Hutch; synonym: Drypetes natalensis var. natalensis 
Drypetes natalensis (Harv.) Hutch (locally called “Natal drypetes or Natal ironplum” in English; in 
Southern Africa: “Natalsysterpruim, stinkbos, iKushwane elikhulu, umBejiza, umGunguluza, 
umGunguluzane, umKushwane” by Zulu and “umKhiwane” by Xhosa) grows in Mozambique, 
Tanzania, South Africa, Kenya, and Malawi. It is predominantly used for the treatment of malaria and 
other ailments in Tanzania (Gessler et al., 1995). 
3.1.9. Drypetes pellegrini Leandri; synonym: Drypetes vignei Hoyle 
Drypetes pellegrini Leandri (locally called “omenewa-hoakoa” in Ghana) is endemic to Ghana and 
Ivory Coast. The bark is used as an Ivorian multi -purpose medicine (Aubréville, 1959). 
3.1.10. Drypetes roxburghii (Wall.) Hurus.; synonym: Putranjiva roxburghii Wall. 
Drypetes roxburghii (Wall.) Hurus. (locally called “Amulet-Plant or Wild Olive or Child-Life-Tree” 
in India) grows in The United States, India, Papua New Guinea, Taiwan, and Trinidad and Tobago; it 
was introduced for cultivation to Subsaharan countries for a variety of medicinal applications. The 
leaves are used in India in the treatment of catarrh, skin disease, fever, cold, rheumatism and sterility 
(Chopra et al., 1970b), and fruit, seeds and leaves have various application as an aphrodisiac, a tonic 
to aid conception and for the treatment of filarial diseases (Kumar,  2014c). Crushed seeds are applied 
to insect bites by the S-Pitonj, MP-Pitinjia, and M-Pitaunji tribes in the Bihar region, India (Kumar 
et al., 1998); the leaves and fruit are also used in India for the treatment of muscle twisting, arthralgia 
and rheumatism (Shahwar et al., 2012). Among the tribes of Uttar Pradesh, India, scattered leaves are 
spread on the maternity room floor for an easy delivery, and a garland of its dried seeds is worn to 
protect from red pimples and allergy (Singh and Bisht, 1999). Unspecified parts of the tree are 
reported to be used in India against cold, fever, rheumatism and inflammation (Sudharshan et al., 
2009). In the 'Chatara' block of district Sonebhadra, Uttar Pradesh, India against various parts of the 
plant are used to treat cold, dysentery, fever, as well as an aphrodisiac, stimulant and spermopoietic; 
leaf sap is used as an optic lavage to wash infected eyes (Singh et al., 2010). In the Vidarbha region, 
Maharashtra, India, the leaf is used for the treatment of viral fever (Kumar and Chaturvedi, 2010). In 
Gorakhpur division, India, leaves and stones are given as a decoction for cold, fever and rheumatism 
(Pandey and Tripati, 2011), and tribes of the Sirmour district, Himanchal Pradesh, India, orally apply 
the nuts  to aid conception and promote the birth of a male child (Thakur, 2011). In Nagpur, India, 
the plant is traditionally applied used for coughs, cold and fever (Maurya and Dongarwar, 2012). The 
fruit is used in the District of Uttar Pradesh, India as an aphrodisiac, antiinflammatory, for habitual 
abortion, as a laxative in addition to the treatment of elephantiasis, eye infection and sterility (Singh 
and Dubey, 2012). A paste composed of the seeds is given traditionally applied to the forehead for 
the treatment of pain; seeds are also taken orally, for around one month, by women trying to conceive. 
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A leaf poultice along with the leaves of Dalbergia sissoo and Vitex negundo is applied for the 
treatment of joint pain (Kumar, 2012). Traditional use of the leaves and fruit against cold, rheumatism, 
and swollen throat in India has also been reported (Sharma and Bhadange, 2013). The bark is applied 
by the local people in Nalgonda and Warangal districts of Andhra Pradesh, India for the treatment of 
cough (Sreeramulu et al., 2013). In the Khulna division, Bangladesh it is used for its curative 
properties in folk medicine for the treatment of cardiovascular diseases (Mollik et al., 2009). 
Traditional healers in Bangladesh apply the plant for the treatment of gastrointestinal disorders: 250 
mg of powdered seeds are taken every 4 h with a little sugar and water (Kadir et al., 2013).  
3.2. Phytochemistry 
Chemical investigation of the species of the Drypetes genus began when Puntambekar (1950) 
reported three thiocyanate-derived compounds, 1-thio-β-D-glucopyranose-2-methyl-N-
(sulfooxy)propanimidoyl (glucoputranjivin, 1), (2S) 1-thio-β-D-glucopyranose-N-(sulfooxy)-sec-
butylanimidoyl (glucojiaputin, 2) and its isomer (2R) 1-thio-β-D-glucopyranose-N-(sulfooxy)-sec-
butylanimidoyl (glucocochlearin, 3) from the steam volatile oil of wet kernels of the Asian D. 
roxburghii. In addition, two glucoside compounds, (2S) 1-thio-β-D-glucopyranose-N-(sulfooxy)-2-
hydroxymethylbutylisothiocyanate (glucocleomine, 4) and (2S) 1-thio-β-D-glucopyranose-N-
(sulfooxy)-2-methylbutylisothiocyanate (5) were identified from the seeds and from the volatile 
hydrolysis product from kernels (Fig. 2) (Kjaer and Friis, 1962, Kjaer and Thomson, 1962). In the 
years that followed, a number of new and known compounds were isolated from this species, but 
realistically, chemical research on African species did not start before 1997.  
 
Figure 2. Structures of compounds 1-5 
 
In the meantime, nineteen African and Asian species have been investigated providing a total of 142 
compounds, belonging to various classes of secondary metabolites.  
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3.2.1. Triterpenoids 
Three main classes of triterpenoids were isolated from this genus: one linear triterpenoid, squalene 
(6), from the leaves of D. hieranensis Hayata (Pax & K. Hoffm.) (Chen, 1999) as well as in huge 
quantities from the leaves and stems of D. cumingii Baill. (Pax & K. Hoffm.) (Sun, 2014); one 
tetracyclic triterpenoid, 3β-acetoxycycloart-24-en-23-one (7) reported from the leaves of D. 
roxburghii (Mukherjee, 2012) (Fig. 3); and five subclasses of pentacyclic triterpenoids (friedelane, 
oleanane, lupane, hopane and adianane).  
 
 
Figure 3. Structures of compounds 6 and 7 
 
3.2.1.1. Pentacyclic triterpenoids 
3.2.1.1.1. Friedelane  
The first friedelane (Fig. 4) isolated from this genus was putanjivadione (8) from the trunk bark of 
the Asian D. roxburghii (Garg and Mitra, 1968b) and it was shown to be friedelane-3,7-dione 
(Sengupta and Chakraborty, 1968). Subsequently, the compound was re-isolated from the African 
species D. gossweileri (Sow et al., 1994; Ngouela et al., 2003; Wandji et al., 2003); D. molunduana 
Pax. & K. Hoffm. (Wandji et al., 2000); D. chevalieri (Wansi et al., 2006, 2007); D. gerrardii 
(Ng´ang´a et al., 2008); D. laciniata Pax. (Hutch.) (Fannang et al., 2011); the Asian D. hainanensis 
Merr. (Chen et al., 2014) as well as from D. roxburghii (Sengupta and Mukherjee, 1968; Chopra et 
al., 1970b, Mukherjee et al., 2012). The synthetic compound 7,8-epoxyfriedelane (9) was produced 
by a series of chemical reactions from putranjivadione (8) (Dey and Banerjee, 1995). Three isomers 
of this compound, drypemolundein B (10), 3-oxofriedelan-25-al (11) and 3,15-dioxofriedelane (12) 
were isolated from eight Cameroonian species: D. molunduana, D. gossweileri (Wandji et al., 2000, 
2003), D. chevalieri (Wansi et al., 2007), D. parvifolia (Müll. Arg.) Pax. & K. Hoffm. (Nenkep et al., 
2008), D. tessmanniana Pax. (Pax. & K. Hoffm.) (Dongfack et al., 2008), D. paxii Hutch. (Chiozem 
et al., 2009), D. inaequalis Hutch. (Awanchiri et al., 2009) and D. laciniata (Fannang et al., 2011). 
Friedelin (13), a compound originally described from cork by Chevreul in 1807, was reported from 
the two Asian species D. roxburghii (Garg and Mitra, 1968b; Sengupta and Mukherjee, 1968; Chopra 
et al., 1970b; Mukherjee et al., 2012) and D. hainanensis (Chen et al., 2014) and, in the following as 
O
76
O
H3C
O
13 
 
well from the African species D. gossweileri (Sow et al., 1994; Ngouela et al., 2003, Wandji et al., 
2003), D. littoralis (C. B. Rob.) Merr. (Lin et al., 2001), D. chevalieri (Wansi et al., 2006, 2007), D. 
gerrardii (Ng´ang´a et al., 2008, 2012), D. parvifolia (Nenkep et al., 2008), D. tessmanniana 
(Dongfack et al., 2008), D. paxii (Chiozem et al., 2009), D. inaequalis (Awanchiri et al., 2009), and 
D. laciniata (Fannang et al., 2011). Its isomer friedelan-7-one (14) was isolated from D. paxii 
(Chiozem et al., 2009). Two trioxofriedelanes, 3,6-dioxo-D:A-friedo-oleanan-24-al (15) and 3β-
hydroxyfriedelane-7,12,22-trione (16) were isolated from D. chevalieri (Wansi et al., 2007) and D. 
laciniata (Fannang et al., 2011), respectively. Furthermore, friedelan-3β-ol (17), its stereoisomer 
epifriedelanol (18), epifriedelanol methyl ether (19) and 5β,24-cyclofriedelan-3-one (20) were 
isolated from D. amoracia (Wandji et al., 2003), D. tessmanniana (Dongfack et al., 2008) and D. 
gerrardii (Ng´ang´a et al., 2008, 2012; Hata et al., 2014). Friedelane-3α,16β-diol (21), its isomer 
friedelane-3β,29β-diol (22) and the oxydized isomer 3-oxo-friedelan-29-ol (23) were reported from 
D. hieranensis and D. congestiflora Chuin & T. Chen. (Chen et al., 1999, Chen, 2015). Furthermore, 
from the Camerooninan species D. paxii and D. inaequalis as well as the two Asian species D. 
hoanensis Gagnep. and D. roxburghii, four compounds were isolated, namely 12α-hydroxyfriedelane-
3,15-dione (24), 3β-hydroxyfriedelan-25-al (25), 3α-hydroxyfriedelan-7-one (26), 3α-
hydroxyfriedelan-12-one (27), 3α-hydroxyfriedelan-25-al (28) and roxburghonic acid or 3-
ketofriedelan-25-oic acid (29) (Garg and Mitra, 1968b, 1971a; Awanchiri et al., 2009; Chiozem et al., 
2009; Wittalai et al., 2014). Four seco-friedelane, putanjivic acid or 3,4-sec-friedelan-4(23)-en-3-oic 
acid (30), methylputranjivate (31), putranjic (putric) acid or 2-hydroxy-3,4-seco-D:A-friedooleanan-
3-oic acid (32) and methylputranjate (33) were isolated from D. roxburghii (Garg and Mitra, 1968b, 
1969; Chopra et al., 1968, 1970a; Aojagi et al., 1973). Five nor-friedelane, hainanenone or 4-
hydroxy-23-nor-friedel-3-one (34), hainanenone A or 23-nor-friedel-3-one (35), putrone or 3-oxo-
25-nor-friedel-9(11)-ene (36), putrol or 3α-hydroxy-25-nor-friedel-9(11)ene (37) and putralone or 
10α-hydroxy-25-nor D:A friedo-olean-9(11)-en-3-one (38) were isolated from D. hainanensis (Chen 
et al., 2014; He et al., 2015) and D. roxburghii (Chopra et al., 1968; Aiyar et al., 1973; Mukherjee et 
al., 2012). The suggested structure of 36 was supported by its conversion into D:A-friedo-oleana-7,9 
(11)-diene, and it was also reported to have been synthesized from 25-acetoxy-D:A-friedo-olean-7-
ene (Sengupta et al., 1979). The compounds 3α-(E)-caffeoyloxyfriedelan-7-one (39) and 3α-(E)-p-
coumaroyloxyfriedelan-7-one (40) were isolated from the DCM extract of the roots of D. hoanensis 
(Wittalai et al., 2014). 
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Figure 4. Structures of compounds 8-40 
 
3.2.1.1.2. Oleanane 
The isolated oleananes (Fig. 5) of this genus belong to the class of olean-12-ene. From the EtOH 
extract of the stems of D. littoralis, α-amyrin (41) was reported (Lin et al., 2001), as well as from the 
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EtOH extract of leaves and stems of D. hainanensis (Chen et al., 2014). Its isomer β-amyrin (42) was 
also obtained from the DCM-MeOH (1/1) extract of the stem of D. chevalieri (Wansi et al., 2007); 
the leaves of D. roxburghii (Badole et al., 2011); and the EtOH extract of leaves and stems of D. 
hainanensis (Chen et al., 2014). Furthermore, β-amyrone (43) was isolated from the MeOH extract 
of the stem bark of D. gossweileri. In addition, erythrodiol (44), bayogenin acid (45), hederagenin 
(46) and 3β-acetoxyolean-12-en-28-oic acid (47) were isolated from the DCM-MeOH (1:1) stem 
extract of D. molunduana (Wandji et al., 2000). Erythrodiol (44) and oleanolic acid (48) were also 
reported to be obtained from the DCM-MeOH (1:1) extract of D. chevalieri (Wansi et al., 2006, 2007) 
and the leaves of D. roxburghii (Mukherjee et al., 2012). D. gossweileri contained maslinic acid (49) 
(Sow et al., 1994). The air-dried stems and ripe fruit of D. inaequalis provided the 28β-D-
glucopyranosyl-30-methyl-3β-hydroxyolean-12-en-28,30-dioate (50) along with serjanic acid (51), 
28β-D-glucopyranosyl-3β-hydroxyolean-12-en-28-oate (52), serratagenic acid (53) and queretaroic 
acid (54) (Awanchiri et al., 2009). From the MeOH extract of the whole stem of D. laciniata, the 
known compounds oleanolic acid (48), 3β,22β-dihydroxyolean-12-en-28-oic acid (55), and 
chikusetsusaponin IVa methyl ester (56) were isolated. Furthermore, the EtOH/H2O (95/5) extract of 
the twigs and leaves of D. perreticulata contained collinsogenin (57) (Ge et al., 2014). A crystalline 
triterpenoid saponin named putranjivoside (58) was isolated from the seed coat of D. roxburghii and 
was established to be 3β-L-arabino-L-rhamno-D-glucoside of oleanolic acid (Garg and Mitra, 1968a). 
Furthermore, the benzene extract of the leaves of D. roxburghii gave β-amyrin (42) and a β-amyrin 
palmitate (59) (Chopra et al., 1968). The DCM-MeOH (1:1) extract of the stem of D. chevalieri 
afforded a triterpenoid named drypechevalin A or 11-oxo-β-amyrin-3β-ylcaffeate (60) (Wansi et al., 
2006). From the MeOH extract of the stem bark of D. tessmanniana, a 3β-O-(E)-3,5-
dihydroxycinnamoyl-11-oxo-olean-12-ene (61) was reported (Dongfack et al., 2008). From the 
DCM-MeOH (1:1) extract of the leaves of D. gerrardii, the saponin putranoside A (62) was isolated 
(Hata et al., 2014).  
 
17 
 
 
 
 
 
 
HO
41.
R4
R2
42. 
 R1
 = H; 
 R2
 = OH; 
 R3
 = R4
 = CH3
44. 
 R1
 = H; 
 R2
 = OH; 
 R3
 = CH3; R4
 = CH2OH
45. 
 R1
 = R2
 = OH; 
 R3
 = CH2OH; R4
 = COOH
46. 
 R1
 = H; 
 R2
 = OH; 
 R3
 = CH2OH; R4
 = COOH
47. 
 R1
 = H; 
 R2
 = OAc; 
 R3
 = CH3; R4
 = CH2OH
48. 
 R1
 = H; 
 R2
 = OH; 
 R3
 = CH3; R4
 = CH2OH
R3
O
43.
R1
COOH
HO
HO
HO
R
O
O
HO
O
OH
OH
OH
49. 50. 
 R = COOCH3
52. 
 R = CH3
COOH
HO
R2
O
O
O
HO
O
OH
OH
OH
56.
R1
51. 
 R1
 = H; 
   R2
 = COOCH3
53. 
 R1
 = H; 
   R2
 = COOH
54. 
 R1
 = H; 
   R2
 = CH2OH
55. 
 R1
 = OH; R2
 = CH3
O
HO
HO
OH
MeOOC
COOH
HO
57.
CH2OH
CH2OH
OH
COOH
O
58.
D-Glc-L-Rha-L-Ara
18 
 
 
 
 
Figure 5. Structures of compounds 41-62 
 
3.2.1.1.3. Lupane 
The DMC-MeOH (1:1) extract of the stem of D. chevalieri afforded lupeol (63) (Wansi et al., 2006; 
2007), which was subsequently also reported from the MeOH extract of the stem bark of D. 
tessmanniana (Dongfack et al., 2008), and the EtOH extract of leaves and stems of D. hainanensis 
(Chen et al., 2014) (Fig. 6). Furthermore, the DCM-MeOH (1:1) extract of the stems of D. chevalieri 
afforded lupeone 64 (Wansi et al., 2006), and the air-dried 95% EtOH/H2O extract of the stems of D. 
congestiflora delivered betulinic acid (65) (Chen et al., 2015). In addition, the crude ethyl acetate and 
DCM extracts of the stem of D. gerrardii delivered resinone (66) (Ng'ang'a et al., 2011, 2012). The 
stems and ripe fruit of D. inaequalis afforded lup-20(29)-en-3β,6α-diol (67) and 3β-acetoxylup-
20(29)-en-6α-ol (68) (Awanchiri et al., 2009). From the MeOH extract of the stem bark of D. 
tessmanniana, 3β,6α-dihydroxylup-20(29)-en (69) was isolated (Dongfack et al., 2008). From twigs 
and leaves of D. perreticulata extracted with EtOH/H2O (95/5) messagenic acid D (70) and G (71), 
betulonic acid (72), 2α,3α-dihydroxy-lup-20(29)-en-28-oic acid (73), nor-29-lupane and platanic acid 
(74) were isolated (Ge et al., 2014). Platanic acid (74) was as well isolated from the air-dried 95% 
EtOH/H2O extract of the stems of D. congestiflora (Chen et al., 2015). Furthermore, four 
caeffeoyllupane derivatives were isolated from this genus, namely 3β-caffeoylbetulinic acid (75) from 
60. 
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the stems of D. congestiflora (Chen et al., 2015), 3β-caffeoyloxylup-20(29)-en-6α-ol (76) from the 
air-dried stems and ripe fruit of D. inaequalis (Awanchiri et al., 2009) and two isomers betulin-3β-
(Z)-caffeate (77) and betulin-3β-(E)-caffeate (78) from twigs and leaves of D. perreticulata Gagnep. 
(Ge et al., 2014). 
 
 
 
 
Figure 6. Structures of compounds 63-78 
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3.2.1.1.4. Hopane and adianane 
The EtOAc and DCM extracts of the stem of D. gerrardii afforded 3β-epimoretenol (79) (Ng'ang'a et 
al., 2008, 2012), while the leaves of D. roxburghii revealed two adiananes, namely 3β-acetoxyadiane-
5-ene (80) and adian-5-en-3β,29-diol (81) (Mukherjee et al., 2012) (Fig. 7).  
 
 
Figure 7. Structures of compounds 79-81 
 
3.2.2. Steroids 
Seven stigmastane-type steroids were isolated from this genus (Fig. 8). Stigmasterol stearate (82), β-
sitosterol stearate (83), stigmasterol (84) and β-sitosterol (85) were reported from the bark of D. 
gossweileri (Dupont et al., 1997). Stigmasterol (84), β-sitosterol (85) and their glycosylated 
derivatives 3-O-β-D-glucopyranosylstigmasterol (86) and 3-O-β-D-glucopyranosyl-β-sitosterol (87) 
were isolated from the leaves of D. hieranensis (Chen et al., 1999), the stem bark of D. parvifolia 
(Nenkep et al., 2008), the stem bark of D. tessmanniana (Dongfack et al., 2008), the stems of D. 
gerrardii (Ng'ang'a et al., 2008), the stems of D. paxii (Chiozem et al., 2009), the stems and ripe fruit 
of D. inaequalis (Awanchiri et al., 2009), the whole stem of D. laciniata (Fannang et al., 2011) and 
the leaves and stems of D. hainanensis (Chen et al., 2014). Furthermore, 3β-hydroxysigmasta-5,22-
dien-7-one (88) was isolated from the DCM extract of the roots of D. hoaensis (Wittayalai et al., 
2014). 
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Figure 8. Structures of compounds 82-88 
 
3.2.3. Diterpenes 
Ten dinorditerpenoids belonging to the pimarane class with the armoratic ring C, were reported from 
this genus (Fig. 9). Chemical investigation of the EtOH extract of the stem of D. littoralis yielded 
three tricyclic diterpenes namely drypetenone A or 10S-12-hydroxy-11-methoxy-13-
methylpodocarpa-1,5,8,11,13-pentaene-3,7-dione (89), drypetenone B or 10S-12-hydroxy-11-
methoxy-13-methylpodocarpa-5,8,11,13-tetraene-3,7-dione (90), and drypetenone C or 10S-12-
hydroxy-6,11-dimethoxy-13-methylpodocarpa-1,5,8,11,13-pentaene-3,7-dione (91) (Lin et al., 
2001). In addition, from the DCM-MeOH (1:1) stem extract of D. gerrardii, a phenanthrenone 
derivative, drypetenone D (92), and a phenanthrenone heterodimer, drypetenone E (93) were isolated 
(Hata et al., 2014). Furthermore, a podocarpane derivative named gossweilone or 6,12-dihydroxy-
13-methylpodocarpa-5,8,11,13-tetraene-3,7-dione (94) was isolated from the MeOH stem bark 
extract of D. gossweileri (Ngouela et al., 2003). The twigs and leaves of D. perreticulata extracted 
with EtOH/H2O (95/5) afforded dryperrein A or (10S)-11,12-dihydroxy-6-methoxy-15,16-
dinorpimara-5,8,11,13-tetraene-3,7-dione (95), dryperrein B or (10S)-6,11,12-trihydroxy-15,16-
dinorpimara-5,8,11,13-tetraene-3,7-dione (96), dryperrein C or (10S)-11,12-dihydroxy-6-methoxy-
15,16-dinorpimara-1,5,8,11,13-pentaene-3,7-dione (97), and dryperrein D or (10S)-6,11,12-
trihydroxy-15,16-dinorpimara-1,5,8,11,13-pentaene-3,7-dione (98) (Ge et al., 2014). 
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Figure 9. Structures of compounds 89-98 
 
3.2.4. Sesquiterpenes 
The first sesquiterpene isolated from the genus was drypemolundein A (99) (Fig. 10), which was from 
the DCM/MeOH (1:1) extract of the stem of D. molunduana (Wandji et al., 2000). This sesquiterpene 
with the original structure did not follow the isoprenyl rule, since its structure contains two units of 
isoprenyl and one linear pentane. Furthermore, eight eremophilane sesquiterpenes were isolated, 
namely furanoeudesm-1-on-13-oic acid (100) from the stem of D. chevalieri (Wansi et al., 2007), 1α-
hydroxyeremophila-6,9,11-trien-8-one (101) and 4α-hydroxyeremophila-1,9-diene-3,8-dione (102) 
from the stems of D. congestiflora (Chen et al., 2015), as well as hoaensibenzofuranal (103), 
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hoaensieudesone (104), hoaensifuranonal (105), hoaensieremodione (106), hoaensieremone (107) 
and the known compound warburgin (108) from the the roots of D. hoaensis (Wittalajai et al., 2014). 
A linear sesquiterpene alcohol, nerolidol (109) was isolated from leaves and stems of D. cumingii 
(Sun et al., 2014).  
 
Figure 10. Structures of compounds 99-109 
 
3.2.5. Phenylpropanoids and phenylethanoid 
Syringin methyl ether (110) was the first phenyl propanoid glycoside reported from this genus (Fig. 
11), and was isolated from D. roxburghii (Sipahimalani et al., 1994). Furthermore, phenylpronanoid 
glycoside named drypearmoracein A or (E)-4,5,6,7-tetrahydroxy-2-benzylhept-2-enoic acid (111) 
was reported from the MeOH stem bark extract of D. amoracia (Wandji et al., 2003). Phytochemical 
investigation of D. hainanensis resulted in the isolation of three phenylpropanoids named drypetesins 
A-C (112-114) (Zhang et al., 2015). From the DCM extract of the roots of D. hoanensis as well as 
the ethanolic extract of the stem of D. littoralis, coniferaldehyde or 4-hydroxy-3-
methoxycinnamaldehyde (115), sinapaldyehde or 4-hydroxy-3,5-dimethoxycinnamaldehyde (116) 
and 3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone (117) were reported (Lin et al., 2001, 
Wittayalai et al., 2014). In addition, the phenylethanoid N-β-glucopyranosyl-p-
hydroxyphenylacetamide (118) was isolated from the MeOH extract of the bark of D. gossweileri 
(Matochko, 2010, Ata et al., 2011).  
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Figure 11. Structures of compounds 110-118 
 
3.2.6. Lignanes 
The MeOH extract of the leaves of D. roxburghii revealed (+)-syringaresinol-4'-O-β-D-
glucopyranoside (119), (-)-syringaresinol-4',4"-O-β-D-diglucopyranoside (120) and (-)-pinoresinol-4' 
-O-β-D-glucopyranoside (121) (Sipahimalani et al., 1994). In addition, (-)-syringaresinol (122) 
reported from the DCM/MeOH (1:1) extract of the stem of D. molunduana (Wandji et al., 2000) was 
as well isolated from the ethanolic extract of the stem of D. littoralis (Lin et al., 2001) and the DCM 
extract of the roots of D. hoaensis (Wittayalai et al., 2014). Furthermore, smilaside C (123) was 
isolated from the DCM extract of the roots of D. hoaensis (Wittayalai et al., 2014), and the ethanolic 
extract of the stem of D. littoralis gave lariciresinol (124), the neolignan boehmenan (125), and the 
neolignan boehmenan D (126) (Lin et al., 2001) (Fig. 12).  
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Figure 12. Structures of compounds 119-126 
 
3.2.7. Flavonoids, xanthone and anthraquinone 
From the crude extract of D. gerrardii, drypetdimer A (127) was isolated (Ng'ang'a et al., 2011) (Fig. 
13), while the DCM extract of the stem contained amentoflavone (128) (Ng'ang'a et al., 2012). The 
latter was previously reported from the EtOH extract of the stem of D. littoralis (Lin et al., 2001). 
Furthermore, the extract of the stem bark of D. parvifolia delivered a flavan glycoside, 7-hydroxy-5-
O-β-D-glucopyranosideflavan (129), and an unusual chalcone glycoside, (Z)-4´,6´-dihydroxy-2´-O-
β-D-glucopyranosidechalcone (130) (Nenkep et al., 2008), while the EtOH extract of fresh leaves of 
D. roxburghii yielded gallocatechin (131) (Chopra et al., 1970b). In addition, a biflavonoid, namely 
putraflavone or 7,4′'′-dimethyl amentoflavone (132), was isolated from the acidic fraction of the 
alcoholic extract of the leaves of this plant (Garg and Mitra, 1971b). Finally, xanthone 1-hydroxy-7-
hydroxymethyl-6-methoxyxanthone (133) and anthraquinone drypearmoracein B or 2,3-dihydroxy-
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9,10-tetrahydroanthra-1,4-quinone (134) were reported from the stem of D. littoralis (Lin et al., 
2001), respectively, from the MeOH extract of the stem bark of D. armoracia (Wandji et al., 2003).  
 
 
Figure 13. Structures of compounds 127-134 
 
3.2.8. Other metabolites  
The DCM extract of the roots of D. hoaensis afforded vanillin (135) and syringaldehyde (136) 
(Wittayalai et al., 2014). Furthermore, the EtOH extract of fresh leaves of D. roxburghii yielded gallic 
acid (137) and ellagic acid (138) (Chopra et al., 1970b), while the CHCl3-soluble fraction of the 
leaves of D. hieranensis afforded the known tannin hexamethoxyellagic acid (139) (Chen et al., 1999) 
(Fig. 14).  
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Figure 14. Structures of compounds 135-139 
Furthermore, stearic acid (140) reported from the bark of D. gossweileri (Dupont et al., 1997). In 
addition, two liposoluble constituents from the leaves and stems of D. cumingii afforded the fatty acid 
ethyl ester ethyl oleate (141) and disparlure or 2-methyl-7R,8S-epoxy-octadecane (142), also a 
pheromone of the gypsy moth (Sun et al., 2014) (Fig. 15).  
 
 
Figure 15. Structures of compounds 140-142 
 
From D. roxburghii seeds, a multifunctional ~12 kDa heterodimeric protein named putrin belonging 
to 2S albumin family was purified, characterised and cloned (Tomar et al., 2014). In addition, a highly 
stable trypsin inhibitor was isolated from the seeds of D. roxburghii. The protein consists of a single 
polypeptide chain of 34 kDa and inhibits bovine trypsin in 1:1 molar ratio (Chaudhary et al., 2008).  
 
3.3. Biological activity of crude extracts and pure compounds  
  
Plants of the genus Drypetes are used in the Subsaharan African and Asian traditional medicines due 
to its broad spectrum of biological and pharmacological activities. The varied ethnomedicinal uses of 
the different species of Drypetes have led to the initiation of many biological investigations. The table 
2 presents the biological activities of crude extracts and some isolated coumpounds. 
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Table 2: Bioactivities and toxicity of  crude extracts and isolated compounds from the genus 
Drypetes 
Plant name Part of 
plant 
Isolated compound 
/ crude extract 
Reported bioactivity  Reference 
D. chevalieri stem furanoeudesm-1-on-
13-oic acid  100 
Antileishmanial   Wansi et al., 2007 
D. congestiflora stem 
 
hoaensieremone 107 Active against human lung 
adenocarcinoma cell line A 549  and 
murine mouse melanoma cell line B16 
F10 
Chen et al., 2015 
D.  gerrardii  crude extract Antiplasmodial and 
antileishmanial   
Hata et al., 2014 
resinone  66 Antiplasmodia and not toxic against 
rat myoblast cell line L6 
Ng'ang'a et al., 
2011; 2012 
 5β,24-
cyclofriedelan-3-
one  20 
Antiplasmodial and mild toxic  against 
rat myoblast cell line L6 
stem drypetenone D  92  Antiplasmodial, antileishmanial, 
antitrypanosomal, not toxic against rat 
myoblast cell line L6 and not active in 
Plasmodium berghei mouse model 
Hata et al., 2014;  
 
 drypetenone E  93 Antiplasmodial, antileishmanial, 
antitrypanosomal and not toxic against 
rat myoblast cell line L6 
leaves 
 
crude extract Antitrypanosomal  
putranoside A  62 Antileishmanial, antitrypanosomal, not 
active against Plasmodium  falciparum 
NF54 and not toxic against rat 
myoblast cell line L6 
D.  gossweileri stem bark 
 
crude extract 
 
Antibacterial, antifungal and 
not toxic in animal experiment 
Ndouga et al., 
1991; 
Ijah and Ojebanji, 
2003; 
Tan  et al., 2006; 
Ngouana et al., 
2010; 2011 
β-amyrone  43, N-β-
D-glucopyranosyl-
p-
hydroxyphenylaceta
mide  117 
Antifungal Matochko, 2010; 
Ata et al., 2011 
cork essential oil Antifungal  Ndonkeu et al., 
2013 
bark stearic acid  140 Active against  human hepatoma cell 
lines HepG2 and Hep3B; low toxic 
against human normal cell line 
Dupont et al., 
1997;  Tang et al., 
2007 
not 
reported 
maslinic acid  49 Antidiabetic Sow et al., 1994;  
Hou et al., 2009 
bark N-β-D-
glucopyranosyl-p-
hydroxyphenylaceta
mide  117,  β-
amyrone 43 
Antidiabetic Matochko, 2010; 
Ata et al., 2011 
stem bark crude extract Analgesic in animal experiment Bomba et al., 
2013 
bark 
 
N-β-D-
glucopyranosyl-p-
hydroxyphenylaceta
mide  117 
Acetylcholinesterase inhibition,   Matochko, 2010; 
Ata et al., 2011 
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crude extract Insecticidal against  Sitophilus zeamais 
and  Rhyzopertha dominica 
Aba et al., 2013 
D.  hainanensis stems + 
leaves 
crude extract Antioxidant  Chen et al., 2011; 
2014 
leaves hainanenone  34 Active against   human  hepatom cell 
line BEL7402, human lung 
adenocarcinoma  
drypetesin A  112, 
drypetesin B  113, 
drypetesin C  114 
Active   against human hepatoma cell 
line HepG2, human breast 
adenocarcinoma cell line MCF-7, and 
human lung carcinoma cell line A-549 
cancer cell lines 
 
Zhang et al., 2015 
D. hoaensis roots 
 
(E)-
caffeoyloxyfriedela
n-7-one  39,  3α-
(E)-p-
coumaroyloxyfriede
lan-7-one  40, 3 β-
hydroxyfriedelan-
12-one  27  
hoaensifuranonal  
105, 
hoaensieremodione  
106, 
hoaensieremone  
107  
Active against hepatocarcinoma cell 
line HepG2  
active against acute lymphoblastic 
leukemia cell line MOLT-3 
active against  human 
cholangiocarcinoma cell line  HuCCA-
1 and  hepatocarcinoma cell line 
HepG2 
Wittalai et al., 
2014 
 
D. inaequalis stem lup-20(29)-en-3 
β,6a-diol 67 
Antibacterial 
 
Awanchiri et al., 
2009 
 
ripe fruit 28β-D-
glucopyranosyl-30-
methyl-3β-
hydroxyolean-12-
en-28,30-dioate 50 
D. laciniata whole 
stem 
3β-
hydroxyfriedelane-
7,12,22-trione  16, 
chikusetsusaponin 
IVa methyl ester  56  
Antibacterial Fannang et al., 
2011 
D.  littoralis stem crude extract Antiviral and against Epstein Barr 
virus DNA polymerase 
Chiou, 
unpublished study 
amentoflavone  127 Antiplasmodial and  toxic against rat 
myoblast cell line L6 
Lin et al., 2001;  
Ng'ang'a et al., 
2012 
D.  molunduana stem bark crude extract  Analgesic and antiinflammatory in 
animal experiment  
Wandji et al., 
2000;  Nke et al., 
2001; 2003 drypemolundein  A  
99 
Antiinflammatory and analgesic   in 
animal experiments 
oleanolic acid  48 Antidiabetic Hou et al., 2009 
D.  natalensis bark, root  crude extract Antitrypanosomal, antileishmanial, 
antiplasmodial and not toxic against 
rat myoblast cell line L6  
Malebo et al., 
2009 
D. paxii stems 12β-
hydroxyfriedelane-
3,15-dione  24, 3β-
hydroxyfriedelan-
25-al  25, friedelin 
13,  friedelan-7-one  
14 and  28β-D-
glucopyranosyl-3β-
Antibacterial  Chiozem et al., 
2009 
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hydroxyolean-12-
en-28-oate   52 
D.  
perreticulata 
twigs and 
leaves 
 
crude extract 
 
Antibacterial and  
broad spectrum cytotoxic activity   
Chen et al., 2012 
dryperrein D 98 Antibacterial, antifungal Ge et al., 2014 
 crude extract 
dryperrein A-D 95-
98  
Active  against human lung tumor cell 
line A549 and leukemia cell line HL60 
 
D. roxburghii seeds 
 
putrin  Antibacterial, Dnase and Rnase 
inhibition and antifungal 
Tomar et al., 2014 
crude extract 
 
Not toxic against Artemia salina Raghavendra et 
al., 2010 
stem bark  Highly toxic against Artemia salina Krishnaraju et al., 
2005 
fruits nanoparticles of 
metallic silver  
Antiplasmodial, not toxic against the 
fish  Poecilia reticulata 
Haldar et al., 
2013 
leaves crude extract 
 
Antibacterial and antifungal Kumar et al., 
2006 
leaf + 
fruit 
Antifungal Kuri et al., 2010, 
2011 
leaf essential oil 
 
Antifungal 
 
Tripathi and 
Kumar, 2007; 
2013; 2014a; 
2014b; 
Pandey and 
Tripathi, 2011 
 bark crude extract Active against  human hepatocellular 
carcinoma cell line HepG2 and low 
toxic against Artemia salina 
El-Manawaty et 
al., 2013 
trunc 
bark 
putanjivadione 8 Active against hepatocellular 
carcinoma cell line BEL7402, human 
lung cancer cell line A549 and 
leukemia cell line HL60 
Garg and Mitra, 
1968; Chen et al., 
2014 
leaves crude extract 
 
antidiabetic in animal experiment 
(EtOH extract); acute oral toxicity in 
animal experiment (70% MeOH 
extract); mitosis-disruptive 
chromosomal changes in bone marrow 
cells in animal experiment (80% EtOH 
extract) 
Varma et al., 
2010;  Rajahamsa 
et al., 2013; 
Awashthy et al., 
2000 
seeds Central nerval system depressant 
activity in animal model; not toxic 
against Artemia salina 
Sudharshan et al., 
2009;  
Raghavendra et 
al., 2010 
all parts Antioxidant 
 
Chinmaya et al., 
2009 
stems Shahwar et al., 
2012 
leaf + 
stem 
Rajahamsa et al., 
2013 
leaves Antiinflammatory in animal 
experiment (ether, acetone, MeOH); 
acute oral toxicity in animal 
experiment (70% MeOH extract) 
Reanmongkol et 
al., 2009;  
Kaushik et al., 
2012;  Rajahamsa 
et al., 2013;   
leaves 
seeds 
crude extract 
 
Analgesic in animal experiment 
 
Reanmongkol et 
al., 2009 
Sudharshan et al., 
2009 
seeds trypsin inhibitor  Inhibition of bovine trypsin in a 1:1 
molar ratio 
Chaudhary et al., 
2008 
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crude extract Antiemetic in animal experiment Mughal and 
Mahboob, 2013 
seed 
kernel 
essential oil Insecticidal against  Bruchus pisorum Kumar, 2014b 
volatile constituents 
of essential oil 
Insecticidal against  Trogoderma 
granarium 
Tripathi and 
Kumar, 2007 
D.  sepiaria leaves 
 
crude extract 
 
Active against cervical cancer cell line 
SiHa; antiinflammatory in animal 
experiment, antioxidant and 
anthelmintic against Pheretima 
posthuma 
Gadamsetti et al., 
2013a; 2013b 
D. 
tessmanniana 
stem bark  3β-O-(E)-3,5-
dihydroxycinnamoy
l-11-oxo-olean-12-
ene  61 and  3β,6α-
dihydroxylup-
20(29)-en  69  
 
Antibacterial, not active against  
Candida albicans LMP709U and 
Microsporum audouinii LMP725D 
Dongfack et al., 
2008; Kuete et al., 
2010 
 
3.3.1. Antileishmanial and antitrypanosomal activity 
No species of the genus Drypetes is traditionally used to treat leishmaniasis, African sleeping sickness 
and Chagas disease (trypanosomiasis). However, some crude extracts and compounds have been 
tested on these diseases. The DCM-MeOH (1:1) stem extract of D. gerrardii showed moderate in 
vitro activity against Leishmania donovani MHOM/ET/67/L82 with IC50 7.31 mg/mL. The isolated 
saponin putranoside A 62 and phenanthrenone derivative, drypetenone D 92, showed weak  activity 
against Leishmania donovani with IC50 7.8 µM and 14.0 µM, respectively compared to the positif 
control (miltefosine IC50 of 0.552 µM). The same solvent extract of the leaves showed moderate 
activity against Trypanosoma brucei rhodesiense STIB 900 strain, with IC50 12.1 mg/mL, while the 
same isolated compounds showed weak  activity against Trypanosoma brucei rhodesiense with IC50 
18.0 µM and 6.0 µM, respectively compared to the positif control (melarsoprol IC50 of 0.003 µM) 
(Hata et al., 2014). Malebo et al. (2009) reported the antileishmanial and antitrypanosomal activities 
of the ethanolic stem and the root bark extracts of D. natalensis against Trypanosoma brucei 
rhodesiense STIB 900 with IC50 10.70 µg/mL and against Leishmania donovani MHOM-ET-67/82 
with IC50 19.0 µg/mL for the stem bark, and with IC50 12.10 µg/mL against Trypanosoma brucei 
rhodesiense STIB 900, and IC50 29.7 µg/mL against Leishmania donovani for the root bark. The 
DCM-MeOH (1:1) extract of the stem of D. chevalieri delivered the furanoeudesm-1-on-13-oic acid 
100 which displayed significant antileishmanial activity against Leishmania major (88/DESTO) 
promasitigotes with IC50 40.0 μg/mL compared to the positive control pentamidine with IC50 38.0 
μg/mL (Wansi et al., 2007). Improved "crude" drugs from active fractions of D. natalensis and D. 
chevalieri might be alternatives to modern antileishmanial and antitrypasnosomal drugs, subject to 
careful toxicity studies employing human normal cell lines and toxicity tests in animal model. 
 
3.3.2.  Antiplasmodial activity 
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Five species of Drypetes (D. aubrévillei, D. gerrardii, D. natalensis, D. gossweileri and D. 
roxburghii) have been traditionally used in herbal medicine to treat malaria and fever, and as insect-
repellent. Only three species and the isolated compounds have been assessed for their antimalarial 
activity (Hata et al., 2014; Ng'ang'a et al., 2011; 2012; Lin et al., 2001; Haldar et al., 2013). 
The DCM-MeOH (1:1) stem extract of D. gerrardii inhibited the chloroquine-resistant African 
Plasmodium falciparum NF54 with IC50 0.50 µg/mL. From this extract, the isolated compounds, 
drypetenone D 92 and drypetenone E 93, showing weak activity against Plasmodium falciparum 
NF54 with IC50 0.9 μM and 2.04 μM, respectively compared to the positive control chloroquine with 
IC50 0.004 µM. These compounds also showed a CC50 68.4 µM and CC50 64.0 µM, respectively 
against rat myoblast cell line L6, compared to the positive control podophyllotoxin with CC50 0.019 
µM, resulting in a selectivity index SI 71 and 31.4, respectively. However, drypetenone D 92 was 
inactive in vivo against Plasmodium berghei mouse model (Hata et al., 2014). In addition, 5β,24-
cyclofriedelan-3-one 20 isolated from the EtOAc extract of the stem of D. gerrardii, exhibed 
antiplasmodial activity with IC50 2.2 µg/mL compared to the positive control chloroquine with IC50 
0.063 and artemisinin with IC50 0.002. This compound displayed and CC50 21.2 µM against rat 
myoblast cell line L6 compared to podophyllotoxin with a CC50 0.009 µM, resulting in a selectivity 
index SI 9.64. Resinone 66 isolated from the same extract, displayed high antiplasmodial activity 
with IC50 0.09 µg/mL and displayed and CC50 of 84.8 µM against rat myoblast cell line L6, resulting 
in a favourable selectivity index of 942.2 (Ng'ang'a et al., 2011; 2012). Lin et al., (2001) reported the 
potent antiplasmodial activity of amentoflavone 128 with IC50 2.6 µg/mL, compared to the positive 
control chloroquine with IC50 0.063 µg/mL and artemisinin with  IC50 0.002 µg/mL, but Ng'ang'a et 
al. (2011; 2012) indicated that the activity observed was probably due to the toxicity rather than 
selective activity against the parasite. The EtOH extract of the root bark of D. natalensis displayed 
IC50 1.06 µg/mL against the chloroquine-resistant Plasmodium falciparum K1 (Thailand) compared 
to chloroquine with IC50 0.063 μg/mL and artemisinin with IC50 0.002 μg/mL, and a CC50 19.0 against 
rat skeletal myoblast cell line L-6. Activities resulted in an SI value of 17.9, indicating no toxicity 
when applied in antiplasmodial therapy. Furthermore, the EtOH extract of the stem bark displayed an 
IC50 1.42 µg/mL against Plasmodium falciparum K1 compared to chloroquine with IC50 0.063 μg/mL 
and artemisinin with IC50 0.002 μg/mL, and a CC50 88.9 against rat skeletal myoblast cell line L-6. 
Activities resulted in an SI 62.61 (Malebo, 2009), indicating as well no toxicity when applied in 
antiplasmodial therapy. Interestingly, highly stable silver nanoparticles with average dimension of 
26.6 nm synthesized by dried green fruit of  D. roxburghii displayed strong mosquito larvicidal 
activity against Culex quinquefasciatus and Anopheles stephensi. The 50 % lethal concentration 
(LC50) values for second, third and fourth larval instars after 24 h of exposure to the nanoparticles 
were 0.8632, 1.1619, and 1.2814 ppm against Culex quinquefasciatus, and 0.7329, 0.8397 and 0.9848 
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ppm against Anopheles stephensi, respectively. Toxicity tests on the non-target organism Poecilia 
reticulata (Pisces) showed no harmful effect at 0.8397 ppm, the LC50 concentration used for third 
instar A. stephensi larvae (Haldar et al., 2013). The extracts and isolated compounds showed some 
significant antiplasmodial activity associated with a high cytotoxicity against rat skeletal myoblast 
cell line L-6. These result showed that the extract and the compounds can no kill the parasites without 
damaging mammalian cells. However, further research work on D. natalensis is urgently needed 
3.3.3. Antibacterial  activity 
All species of the genus Drypetes are locally used as antimicrobial agents. Due to the prevalence of 
multi-drug resistant bacteria and their low susceptibility to antibiotics, nearly all extract have been 
tested for their antibacterial activity. The DCM extract of the stem bark of D. gossweileri showed 
antibacterial activity with MIC values of 0.25 to 1.00 mg/mL against Staphylococcus aureus, 
Streptococcus faecalis, Shigella dysenteriae, Yersinia enterocoleteca, Enterobacter cloacae and 
Salmonella sp. (Ndouga et al., 1991). The aqueous and ethanolic extracts of the stem bark clearly 
inhibited S. aureus, Pseudomonas aerugosina, Klebsiella sp., Proteus sp. and Escherichia coli, 
causative agents of urinary tract infections, with the ethanol extract exhibiting the highest inhibitory 
activity with MICs ranging between 3% and 7% (Ijah and Oyebanji, 2003). Furthermore, the DCM-
MeOH (1:1) extract of the bark displayed antibacterial activity against Helicobacter pylori strain 
CCUG 39500 with MIC 0.78 mg/mL compared to amoxicillin with 0.0062 mg/mL and against 
Campylobacter jejuni/coli strain CPC-022004 as well with 0.78 mg/mL, compared to amoxicillin 
with MIC 0.0062 mg/mL (Tan et al., 2006). Importantly, Ngouana et al., (2010) reported that the 
extract did not show any signs of toxicity in rats up to 1000 mg/kg dose, with the exception of male 
rats at 1000 mg/kg dose where a light diminution in body weight was observed. Morphological 
examination of various organs and statistical analysis of relatives organs weight revealed that there 
were no differences between the control groups which received distilled water and maize oil and 
treated rats. Furthermore, lup-20(29)-en-3β,6α-diol 67 and 28β-D-glucopyranosyl-30-methyl-3β-
hydroxyolean-12-en-28,30-dioate 50 isolated from the whole stem of ripe fruit of D. inaequalis, 
assayed by agar diffusion well at a concentrations of 200 µg/mL, displaying inhibition zone diameters 
of 11 to 15 mm against S. aureus, E. coli, and Salmonella typhi, compared to the positive control 
gentamycin displaying 34, 35 and 42 mm of inhibition zone (Awanchiri et al., 2009). In addition, 
from the methanol extract of the whole stem of D. laciniata, the isolated compound, 3β-
hydroxyfriedelane-7,12,22-trione 16 showed antimicrobial activity against S. aureus ATCC25922, S. 
typhi ATCC6539, Pseudomonas aeruginosa ATCC27853, E. coli ATCC 10536, with gentamicin as 
positive control angainst E. coli with MIC 256 mg/mL, P. aeruginosa with MIC 256 mg/mL, and S. 
typhi with MIC 512 mg/mL. Chikusetsusaponin IVa methyl ester 56 displaying also inhibitory 
activities on the growth of E. coli with MIC 256 mg/mL and S. typhi with MIC 512 µg/mL (Fannang 
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et al., 2011). From the methanolic stem extract of D. paxii, 12α-hydroxyfriedelane-3,15-dione 24 and 
3β-hydroxyfriedelan-25-al 25 together with friedelin 13, friedelan-7-one 14, and 28β-D-
glucopyranosyl-3β-hydroxyolean-12-en-28-oate 52 were tested in an agar well diffusion assay at 200 
µg/mL displaying inhibition zones of 17, 14, 11, 10, 15 respectively 21 mm against S. aureus, 
compared to gentamycine with 34 mm, while compound 52 was as well active in this assay against 
E. coli with 18 mm and S. typhi with 17 mm, compared to gentamycine displaying 35 respectively 42 
mm of inhibition zone diameter (Chiozem et al., 2009). Furthermore, the extracts of D. perreticulata 
were reported to display marginal antibacterial actvity against S. aureus ATCC 1339, B. subtilis ATCC 
6633, P. aeruginosa ATCC 14886 and E. coli ATCC 8739 (Chen et al., 2012). The twigs and leaves 
of this plant extracted with EtOH/H2O (95:5) afforded dryperrein D 98 which displaying marginal 
activity against S. aureus ATCC 25923, S. epidermidis ATCC 12228, Micrococcus luteus ATCC 9341 
and B. subtilis in a microdilution assay compared to the positive control ofloxacin (Ge et al., 2014). 
3β-O-(E)-3,5-dihydroxycinnamoyl-11-oxo-olean-12-ene 61 and 3β, 6α-dihydroxylup-20(29)-ene 69 
were submitted to paper disc agar diffusion assays employing  methicillin-resistant S. aureus, S. 
faecalis LMP806, B. cereus LMP716, β-lactamase positive E. coli LMP701, ampicillin-resistant 
Klebsiella pneumoniae LMP803, ampicillin-resistant Shigella dysenteriae LMP820, carbenicillin-
resistant Pseudomonas aeruginosa LMP804, and chloramphenicol-resistant Citrobacter freundii 
LMP802. MICs determined at 80 µg per disc. displayed low activities in a range of  > 625 to 156.25 
µg/mL compared to gentamycin with 4.88 to 39.06  µg/mL (Kuete et al., 2010). The DCM-MeOH 
(1:1) extract of the  the leaves of D. roxburghii was reported to show antibacterial activity in a 
preliminary assay using agar dilution-streak method, where extracts were mixed with agar at 500 
µg/mL and 1000 µg/mL and test strains streaked at the solidified surface. At 500 µg/mL, the extract 
completely inhibited the growth of Micrococcus luteus ATCC 9341, Streptococcus faecalis MTCC 
8043 and Staphylococcus epidermidis ATCC 12228 (Kumar et al., 2006). In addition, from seeds 
extract of the plant, a multifunctional ~12 kDa heterodimeric protein named putrin was isolated and 
shown to inhibit weakly Micrococcus flavus and Bacillus subtilis. Values of antibacterial activity were 
not shown (Tomar et al., 2014). Interestingly, it was noted that the methanolic seeds extract was not 
toxic in Artemia salina assay displaying LD50 427.74 µg/mL (Raghavendra et al., 2010). A more 
promising ethnopharmacological approach would be to focus on plants used for the treatment of 
wounds to prevent infections (main causative agent: Staphylococcus aureus), urinary tract infections 
(Escherichia coli), ear infections (Streptococcus pneumoniae), or gonorrhoea (Neisseria gonorrhoea) 
using multiresistant test strains. 
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However, the systematic data on the chemical constituents and their pharmacological activities are 
limited. Thus, studies on the antimicrobial effects and mechanisms of the genus Drypetes are long 
overdue. 
3.3.4. Antifungal activity 
The antifungal properties of the DCM-MeOH (1:1) stem bark crude extract of D. gossweileri were 
assayed by broth dilution method against Candida albicans, C. glabrata, Microsporum langeroinii, 
M. gypseum, Trichophyton rubrum, T. mentagerophytes and  Aspergillus flavus resulting in MICs 
24.41, 48.84, 12500, 12500, 12500, 6250 and 12500 µg/mL, compared to the positive control 
amphothericin with MIC 2.44 µg/mL for Candida, Microsporum species and with MIC 3.125 µg/mL 
for Trichophyton and Aspergillus. Moreover, the extract was tested for acute toxicity on male and 
female albino Wistar rats. Extract doses of 0, 4, 8, and 12 g/kg body weight were administered per os 
to 4 groups of animals of both sex. The rats were observed for  48 h for death and for 7 days for toxic 
effects. Interestingly, no toxic effects were recorded up to a dose of 12 g/kg of body weight (Ngouana, 
2011). From the MeOH extract of the stem bark, the isolated β-amyrone 43 and N-β-glucopyranosyl-
p-hydroxyphenylacetamide 117, exhibiting  activity against C. albicans with MIC 16 µg/mL and 8.0 
μg/mL, respectively (Ata et al., 2011). The aglycone of compound 117 showed weak active in this 
bioassay, with an MIC 32 μg/mL, indicating that this activity migth be due to the presence of a N-
glucose moiety in compound 117 (Matochko, 2010; Ata et al., 2011). At 50 ppm, the essential oil of 
the cork of D. gossweileri inhibited mycelial growth of Colletotrichum dematium and Acremonium 
apii by 100% (Ndonkeu et al., 2013). Dryperrein D 98 isolated from the twigs and leaves of the 
EtOH/H2O (95:5) extract of D. perreticulata displayed antifungal activity against C. albicans ATCC 
1600 and Saccharomyces sake ATCC 26421strains at 50 µg/mL in agar dilution method with 
amphothericin B as positive control (Ge et al., 2014). Furthermore, the DCM -MeOH (1:1) extract of 
the  the leaves of D. roxburghii was reported to show antifungal activity in a preliminary assay using 
agar dilution-streak method, where extracts were mixed with agar at 500 µg/mL and 1000 µg/mL and 
test strains streaked at the solidified surface. At 500 µg/mL, the extract completely inhibited the 
growth of C. albicans MTCC 10231, but not of A. niger MTCC 1344, compared to the positive control 
amphotericin B which showed complete inhibition at 3 µg/mL (Kumar et al., 2006). In addition, 
aqueous leaves and fruit extracts of the same plant showed a reduction to 9.33% of Solanum 
melongena seed infection by A. flavus, Fusarium oxysporum, Curvularia lunata, and Phomopsis 
vexans compared to 66% fungal infection of untreated seeds (Kuri et al., 2010, 2011). The essential 
oil of the same plant was found to be fungicidal and thermostable at its MIs of 400 ppm against A. 
flavus and A. niger.  The oil protected  peanut seeds completely for 6 months at 0.25 and 0.38 mL in 
containers of 250 mL capacity holding 200 g seeds against above fungi and the insect pest 
Trogoderma granarium. It did not exhibit any adverse effect on seed germination, seedling growth 
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and general health and morphology of plants (Tripathi and Kumar, 2007).  The leaves oil of this plant 
inhibited mycelial growth of Aspergillus flavus, A. niger, A. ochraceus, and  A. terreus with 48.48, 
38.75, 15.71, 48.23% at a concentration of 500 ppm and of Fusarium oxysporum, F. solani, F. 
chlamydosporum, F. equestri, F. monoliforme, F. avenaceum, Alternaria solani and  Humicola 
griseus at 700 ppm, the growth of Absidia spinosa, Acremonium album, F. nivale and Penicillium 
funiculosum (95%), and  at 1000 ppm the growth of  Rhinopsus nigricans,  P. chrysogenum, P. 
glabrum and P. oxalicum. Moreover, the fungitoxicity was not destroyed by autoclaving and storage 
upto 120 days (Pandey and Tripati, 2011; Kumar, 2013, 2014a, 2014b). Interestingly, a 
multifunctional ~12 kDa heterodimeric protein named putrin reported from the seeds displayed an 
IC50 value of 34.7 μM  against A. flavus (Tomar et al., 2014). Compounds, 3β-O-(E)-3,5-
dihydroxycinnamoyl-11-oxo-olean-12-ene 61 and 3β, 6α-dihydroxylup-20(29)-ene 69 isolated from 
the methanolic extract of the stem bark of D. tessmanniana, were inactive to paper disc agar diffusion 
assays employing the fungi Candida albicans LMP709U and Microsporum audouinii LMP725D 
(Kuete et al., 2010).  
3.3.5.  Cytotoxic activity 
Hoaensieremone 107 isolated  from the air-dried 95% EtOH/H2O extract of the stems of D. 
congestiflora was shown to exhibit moderate cytotoxic activity against human lung adenocarcinoma 
cell line A 549 as well as murine mouse melanoma cell line B16 F10, with IC50 values of 27.5 
respectively 41.3 µM (Chen et al., 2015). Stearic acid 140 reported from the bark of D. gossweileri 
(Dupont et al., 1997) was reisolated from Oldenlandia diffusa and proven to display significant 
inhibitory effects on the growth of human hepatoma cell lines HepG2 and Hep3B with IC50 90 µM 
respectively 130 µM, and displayed only 20% inhibition of the normal human liver cell line WRL-
68. Mechanistic studies showed that both cell types were more sensitive towards stearic acid when 
comparing with other fatty acids, and potential for hepatoma treatment was suggested (Tang et al., 
2007). Hainanenone 34 isolated from the EtOH extract of the leaves of of D. hainanensis, displayed 
moderate growth inhibitory activity against human hepatom cell line BEL7402, human lung 
adenocarcinoma cell line A549, and human leukemia cell line HL60 at the concentration of 10-5 mol/L 
with 3.0, 9.7 respectively 4.1% inhibition compared to adriamycin displaying 54.4, 72.2 respectively 
89.6% inhibition (Chen et al., 2014). Further phytochemical investigation of  D. hainanensis resulted 
in the isolation of three phenylpropanoids, named drypetesins A-C 112-114 exhibiting potent 
cytotoxic activities against human hepatoma cell line HepG2, human breast adenocarcinoma cell line 
MCF-7, and human lung carcinoma cell line A-549 cancer cell lines with  IC50 values of 5.6, 8,2 and 
6.7 µM for drypetensin A 112, 12.2, 9.4 and 12.5 µM for drypetensin B 113 and 14.8, 12.4 and 10.8 
µM  for drypetensin C 112 compared to doxorubicin displaying 1.3, 0.78 and 0.57 µM  (Zhang et al., 
2015). From the DCM extract of the roots of D. hoanensis, (E)-caffeoyloxyfriedelan-7-one 39, 3α-
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(E)-p-coumaroyloxyfriedelan-7-one 40, and 3α-hydroxyfriedelan-12-one 27 were isolated and 
evaluated against acute lymphoblastic leukemia cell line MOLT-3, human cholangiocarcinoma cell 
line HuCCA-1, human lung cancer cell line A549  and hepatocarcinoma cell line HepG2 displaying 
highly significant cytotoxicity against the latter cell line with IC50 values of 0.1, 3.1, 0.3 µM, 
respectively. Furthermore, five compounds namely hoaensibenzofuranal 103, hoaensieudesone 104, 
hoaensifuranonal 105, hoaensieremodione 106 and hoaensieremone 107 were submitted to 
cytotoxicity assays. Compounds 105 and 107 showed moderate cytotoxic activity against acute 
lymphoblastic leukemia cell line MOLT-3 with IC50  values of 16.8 and 14.6 µM, while compound 
106 showed weak cytotoxic activity with 74.8 µM. Compound 107 was weakly active against human 
cholangiocarcinoma cell line HuCCA-1 and  hepatocarcinoma cell line HepG2 with IC50 of 51.9 and 
72.4 µM (Wittalajai et al., 2014). In addition, the petroleum ether extract of D. perreticulata exhibited 
a broad spectum cytotoxic activity with IC50 from 76.0 to 682.5 µg/mL in MTT assay (Chen et al., 
2012). In vitro cytotoxic activities against human lung tumor cell line A549 and leukemia cell line 
HL60 showed for dryperrein A  95 and B 96 only weak cytotoxicity against human lung cancer cell 
line A549 cell line with IC50 91.72 µM and 88.54 µM, respectively, and against leukemia cell line 
HL60 with IC50 68.59 µM and 65.08 µM, respectively. However, compounds dryperrein C 97 and D 
98 displayed moderate inhibitory activities against A549 cell line, with IC50 of 8.50 and 9.45 µM, 
respectively. Interestingly, compounds 97 and 98 showed strong inhibition against the leukemia cell 
line HL60 with IC50 1.95 and 1.37 µM, respectively. The cytotoxicity results suggested that the 
presence of Δ1 double bond in  dryperrein C 97 and D 98 is crucial to the cytotoxic activities of this 
class of dinorditerpenoids, while alteration of 6-substuent (OH/OMe) has little effect on their 
activities. Adriamycin was used as positive control with IC50 values of 0.47 µM and 0.12 µM against 
human lung cancer cell line A549 and leukemia cell line HL60, respectively (Ge et al., 2014). A 
toxicity profile of these both compounds against humal normal cell lines still needs to be done before 
their medicinal potential can be commented. At 100 ppm, the methanolic bark extract of D. roxburghii 
displayed 93.47 % inhibition of human hepatocellular carcinoma cell line HepG2 compared to the 
positive control adriamycin with 100 %, while Artemia salina used in toxicity assay displayed only 
10% inhibition at this concentration, compared to the leave extract of Annona cherimolia as positive 
control showing 100% inhibition. The negative control DMSO gave 0.6 respectively 3.3% inhibition, 
which was tolerable (El-Manawaty et al., 2013). At 10-5 mol/L, putanjivadione 8 isolated from the 
trunk bark of D. roxburghii (Garg and Mitra, 1968) showed 4.0, 21.1 and 43.1% inhibition of 
hepatocellular carcinoma cell line BEL7402, human lung cancer cell line A549 and leukemia cell line 
HL60 compared to the positive control adriamycin displaying 54.5, 72.2 and 89.6 % inhibition, 
friedelin 13  was inactive in above cytotoxicity assays.  Putranjivadione 8 is a keto derivative, and it 
was observed that the ketone groups at C-3 and C-7 considerably increased the cytotoxicity against 
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tumor cell lines compared to hainanenone 34 and friedelin 13  (Chen et al., 2014). The methanolic 
extract from leaves of D. sepiaria exhibited cytotoxicity against cervical cancer cell line SiHa with 
an IC50 of 10 μg/mL (Gadamsetti et al., 2013a). Positive and negative controls are not reported. 
 
3.3.6. Antidiabetic activity 
No species of the genus Drypetes is traditionally used to treat diabetes. However, some crude extracts 
and compounds have been tested for antidiabetic activity. Maslinic acid 49 and oleonolic acid 48 
delivering α-glucosidase inhibition with an IC50 value of 5.52 respectively 6.29 µg/mL (Hou et al., 
2009). Compound, N-β-glucopyranosyl-p-hydroxyphenyl acetamide 117, isolated from the 
methanolic extract of the bark of D. gossweileri, exhibiting high α-glucosidase inhibitory activity 
with IC50 12.0 μM. Acidic hydrolysis afforded its aglycone, which exhibited an α-glucosidase 
inhibition activity with an IC50 60.0 μM suggesting that the higher potency of compound 117  was 
due to the presence of an N-glucose moiety (Matochko, 2010; Ata et al., 2011). In addition, β-amyrone 
43 exhibited α-glucosidase inhibition with an IC50 value of 12 µM  (Ata et al., 2011). For compounds 
43 and 117, no positive controls and toxicity against normal mammalian cell lines were reported. 
Furthermore, the ethanolic extract of the leaves of D. roxburghii was subjected to antidiabetic activity 
in rats where alloxan monohydrate (120 mg/kg b.w., i.p.) was used as the diabetogenic agent. At a 
dose of 250 mg/kg, significant antihyperglycemic activity on the 4th, 7th and 10th day post treatment 
with fasting blood glucose level of 258.23, 255.85, respectively 252.06 mg/dL compared to the 
positive control glibenclamide at a dose of 10 mg/kg displaying 205.25, 183.18, respectively 178.13 
mg/dL was measured (Varma et al., 2010). However, it should be pointed out that the 70 % methanol 
extract of dried leaves of the same plant showed acute oral toxicity with LD50 500 mg/kg body weight 
in female Wistar albino rats (Rajahamsa et al., 2013), while the 80% EtOH (v/v) leaves extract 
significantly induced mitosis-disruptive chromosomal changes in bone marrow cells of mice when 
administered at 0.5, 1.0 or 2.0 g/kg body weight/day for seven consecutive days (Awasthy et al., 
2000). Further work on the D. gossweileri and the respective compounds regarding toxicity is 
recommended, since they might be a good alternative in Subsaharan countries for the treatment of 
diabetes. 
3.3.7.  CNS depressant activity 
Sudharshan et al. (2009) reported the CNS depressant activity of 100 mg/kg MeOH extract of D. 
roxburghii administered intraperitoneally (i.p.) seedsin a mouse model. Depression of the CNS was 
assessed with a digital actophotometer which operates on photoelectric cells connected with a counter, 
and records when a beam of light falling on the device’s photocell is cut off by a test animal. 
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Locomotion was significantly inhibited (38.59%) 45 mins after dosing compared to 5 mg/kg i.p. 
diazepam (16.35%). 
3.3.8.  Analgesic activity  
A recent investigation of the analgesic properties of an aqueous extract of D. gossweileri stem bark 
in mice and rats (Bomba et al., 2013) revealed that both 100 and 200 mg/kg doses significantly 
decreased nociception induced by intraperitoneally (i.p.) administered acetic acid measured as 
writhing (abdominal constrictions and hind limbs stretching) inhibition percentage of 45.79 and 
66.06% (p < 0.01 and p <0.001), respectively. Similarly, analgesia for neurogenic and inflammatory 
pain were examined in rats by injecting 20 μL of 2.5% formalin into the subplantar of the right 
hindpaw, 1 h after the aqueous D. gossweileri extract had been administered. Sensation of pain was 
quantified from time spent licking the injected paw 0-5 min post-injection (first phase neurogenic 
pain indicator) and 15-30 min post-injection (second phase inflammatory pain indicator). In the first 
phase, 200 mg/kg aqueous extract significantly reduced (47.41% inhibition) pain sensation (p <0.01). 
During the second phase, the effects of the aqueous extract on pain sensation were dose dependent: 
inhibition of 36.27% for 100 mg/kg, 55.84% for 200 mg/kg, and 65.4% for 400 mg/kg aqueous 
extract. Assessment of pain induced by pressure indicated that 100, 200 and 400 mg/kg doses of the 
aqueous extract significantly reduced pain sensation, with maximum inhibition (54.44%) observed 
with 200 mg/kg. The authors concluded that these results suggest the presence of secondary 
metabolites with analgesic properties in the aqueous extract of D. gossweileri (Bomba et al., 2013). 
Pharmacological screening showed significant analgesic effects of a crude stem bark extract of D. 
molunduana and the isolated compound, drypemolundein A 99 (Nkeh et al., 2001, 2003). An ether 
extract of D. roxburghii leaves administered orally at 100, 200, and 400 mg/kg resulted in dose 
dependent analgesic effects, against to counteract writhing pain following acetic acid treatment in 
mice (Reanmongkol et al., 2009). The analgesic activity of the MeOH extract of D. roxburghii seeds 
was evaluated by tail flick method and activity was greater than the standard drug (Sudharshan et al., 
2009). Another D. roxburghii extract showed dose dependent analgesia again in an acetic acid-
induced writhing model, but dose independent activity in hot plate and tail flick models, compared to 
indomethacin (a non-steroidal anti-inflammatory drug, NSAID) (Rajahamsa et al., 2013). 
3.3.9.  Anti-inflammatory activity 
Drypetes species have been traditionally used in herbal medicine to treat inflammation including 
edema and rheumatism; however, only three species have been assayed for their anti-inflammatory 
effects. The pharmacological screening of the stem bark crude extract of D. molunduana showed 
significant anti-inflammatory effects (Nkeh et al., 2001). Drypemolundein A 99 isolated from this 
extract, significantly reduced paw edema with 57.57 % and 66.66 % inhibition at 1 h intervals, 
respectively at doses of 10 and 20 mg/kg  per os. The ether extract of D. roxburghii leaves showed 
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moderate anti-inflammatory activity at (100, 200, and 400 mg/kg, administered orally) in carrageenin-
induced paw edema, decreased croton oil-induced anus edema at 800 mg/kg high dose in rats and 
displayed a dose-dependent (1.25, 2.5, and 5.0 mg/ear) inhibitiion of croton oil-induced ear edema in 
mice (Reanmongkol et al., 2009). Kaushik et al. (2012) reported that the acetone extract of the leaves 
showed significant reduction (32.47% and 24%, respectively) in a rat model of carregeenan or 
dextran-induced inflammation. When orally administered at 500 mg/kg, the 70% MeOH extract of 
D. roxburghii dried leaves and stems showed anti-inflammatory activity by significantly suppressing 
carrageen-induced paw oedema, to comparable indomethacin (15 mg/kg) treatment levels. Croton-
induced ear edema was also significantly reduced (49.2%) when the MeOH extract was applied 
topically (5.0 mg/ear), again to indomethacin comparable levels treatment (59.1%) (Rajahamsa et al., 
2013), while the 80% EtOH (v/v) leaf extract significantly induced mitosis-disruptive chromosomal 
changes in bone marrow cells of mice when administered at 0.5, 1.0 or 2.0 g/kg body weight/day for 
seven consecutive days  (Awasthy et al., 2000). The petroleum ether, EtOAc, MeOH and aqueous 
extracts obtained from leaves of D. sepiaria were tested for anti-inflammatory activity with variable 
results. The MeOH extract inhibited inflammation in vitro to 85-90% as measured by HRBC 
stabilization method; in vivo assessment as measured by the paw edema method revealed 40-45% 
inhibition of inflammation after/upto/at 6 hrs, compared to 50.04% for the standard (Gadamsetti et 
al., 2013a). Further work on the D. molunduana, D. sepiaria and the respective compounds regarding 
toxicity is recommended. This study requires the positive controls for comparative efficacy.  
3.3.10. Antioxidant activity 
The combined ethanol (EtOH) extracts of stem and leaves and additional extracts from petroleum 
ether, EtOAc, butanol and water of D. hainanensis displayed an IC50 of 77.3, 115.2, 51.4, 342.9, and 
205.7 μg/mL as measured by diphenylpicrylhydrazyl (DPPH) and 11,712.2, 10,820.9, 14,386.4, 
1,157.6, and 5,584.1 μmol Fe2+/g as measured by ferric reducing antioxidant power (FRAP) method. 
Results indicate moderate antioxidant activity when compared to ascorbic acid and BHT showing an 
IC50 of 10.7 μg/mL, 47.1 μg/mL for DPPH and 18,022.8 14 568.7 μmol Fe2+/g for FRAP method 
(Chen et al., 2011). As well, the petroleum ether, DCM, EtOAc and MeOH extracts of D. perreticulata 
possess moderate antioxidant activity (Chen et al., 2012). The petroleum ether, EtOAc, MeOH and 
aqueous extracts obtained from D. sepiaria leaves were assessed with an in vitro antioxidant method. 
The MeOH and EtOAc extracts provided the most potent and concentration dependent DPPH radical 
scavenging activity with IC50 values of 95.43 μg/mL and 94.1 μg/mL respectively, compared to the 
ascorbic acid standard of 3.6 μg/mL; the same extracts also had the most potent and concentration 
dependent 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical cation 
decolourisation activity with IC50 values of 67.05 μg/mL and 55.25 μg/mL respectively, compared to 
the standard gallic acid with IC50 of 8.7 μg/mL (Gadamsetti et al., 2013a). Chinmaya et al. (2009) 
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reported the antioxidant activity of a MeOH extract of D. roxburghii measured by the DPPH method 
at 0.5 and 1.0 mg/mL concentrations exhibited high free radical scavenging activity in a dose 
dependent manner with 73 and 88.19% respectively, compared to ascorbic acid (95.04 and 97.30% 
respectively). Antiradical activity of the ethyl acetate extract of D. roxburghii stems was confirmed 
by a decrease in absorbance at 517 nm using the DPPH method. The extract exhibited high activity 
(91.9% inhibition with IC50 4 µg) compared to gallic acid (94.3% inhibition with IC50 2 µg), ascorbic 
acid (92.6% inhibition with IC50 3 µg), and quercetin (87.3% inhibition with IC50 5 µg). The extract 
showed high antioxidant activity when measured by the FRAP method with 638.7 equivalent to 
FeSO4.7H2O (µM), and displayed a higher absorbance of 1.393 at 695 nm for antioxidant capacity 
(TAC), compared to gallic acid with an absorbance of 1.213 (Shahwar et al., 2012). The combined 
extracts of dried D. roxburghii leaves and stems displayed significant DPPH and H2O2 free radical 
scavenging activity in a dose dependant manner, and was only marginally lower when compared to 
the ascorbic acid standard (Rajahamsa et al., 2013). 
3.3.11. Antiviral activity 
In a preliminary study the MeOH extract of D. littoralis was found to possess activity against Epstein-
Barr virus DNA polymerase (Lin et al., 2001). 
3.3.12. DNAse and RNAse inhibition in vitro 
A multifunctional ~12 kDa heterodimeric protein named putrin isolated from the seeds of D. 
roxburghii was purified, characterised and cloned. Putrin  inhibited the protein synthesis with an IC50 
of 6.6 μM and demonstrated a much lower cell-free translational inhibitory activity as compared with 
other 2S proteins and small RIPs (Tomar et al., 2014). 
3.3.13. Bovin trypsin inhibition in vitro 
A highly stable trypsin inhibitor was isolated from the seeds of D. roxburghii. The protein consists of 
a single polypeptide chain of 34 kDa and inhibits bovine trypsin in a 1:1 molar ratio (Chaudhary et 
al., 2008) 
3.3.14. Acetylcholinesterase inhibition in vitro 
N-β-glucopyranosyl-p-hydroxyphenylacetamide 117, showed moderate activity against 
acetylcholinesterase with IC50 78.1 µM compared to galanthamine with 0.9 µM (Matochko, 2010;  
Ata et al., 2011). 
3.3.15. Antiemetic.activity in vivo 
An aqueous extracts of D. roxburghii administered at 25, 50, 75, and 100 mg/kg, displayed a 
significant, dose-deprendent retching reduction in copper sulfate (CuSO4)-induced emesis in four 
days old chicks (61.7, 67.6, 70.8, and 78.9%, respectively) (Mughal and Mahboob, 2013). 
3.3.16. Insecticidal  activity in vitro 
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The ethyl acetate (EtOAc) and DCM extracts of the bark of D. gossweileri were found to be effective 
against the maize weevil Sitophilus zeamais and the grain borer Rhyzopertha dominica at 1.0, 0.5, 
0.250 g/10 mL (Aba et al., 2013). The seed kernel oil of D. roxburghii showed 100% repellency 
against the Indian seed storage insect Bruchus pisorum (Linn.), which was present in all 25 collected 
storage seed samples of Dalbergia sissoo Roxb, at a concentration of 0.02 mL (Kumar, 2014b). 
Volatile constituents extracted in the form of essential oil from D. roxburghii were found to protect 
againsts the insect Trogoderma granarium isolated from stored peanut seeds. This oil protected the 
peanut seeds completely for six months at 0.25 and 0.38 mL in 250 mL containers holding 200 g of 
seeds, and did not exhibit any adverse effects on seed germination, seedling growth as well as the 
general health and morphology of the plants (Tripathi and Kumar, 2007).  
3.3.17. Anthelmintic activity in vitro 
The anthelmintic activity of EtOAc, MeOH and aqueous crude extracts of leaves on the Indian adult 
earthworm, Pheretima posthuma was reported by Gadamsetty et al. (2013b). All D. sepiaria extracts 
tested exhibited concentration-dependent activity of 10-80 mg/mL. The aqueous extract was 
significantly active causing paralysis after 72.2 min at 20 mg/mL, 42.3 min at 40 mg/mL, 12.6 min 
at 60 mg/mL and 8.3 min at 80 mg/mL; death occured after 148.5 min at 20 mg/mL, 101.3 min at 40 
mg/mL, 30.7 min at 60 mg/mL and 14.0 min at 80 mg/mL. For comparison, 10 mg/mL of the standard 
reference drug, piperazine citrate, showed paralysis after 23.4 min and death after 63.2 min. 
3.3.18. Toxicity 
The stem bark and seed extracts of  D. roxburghii revealed significant toxicity in the Artemia salina 
lethality assay, with LD50 values of 1.175 µg/mL and LC50 427.74 µg/mL, respectively (Krishnaraju 
et al., 2005, Raghavendra et al., 2010). The 70 % v/v MeOH extract of dried D. roxburghii leaves 
and stems showed acute toxicity (LD50 500 mg/kg) in female Wistar albino rats following oral 
adminsitration (Rajahamsa et al., 2013). Awasthy et al. (2000) reported the effects of orally 
administered D. roxburghii leaf extract to young weaning Swiss albino mice at 0.5, 1.0 or 2.0 g/kg 
/day for seven consecutive days. The results demonstrated that the leaf extract induced significant 
mitosis-disruptive chromosomal changes in bone marrow cells, although there were no changes in 
the incidence of structural abnormalities among metaphase chromosomes. It was proposed that the 
extract might have interferred with the spindle and other related proteins causing polyploidy, 
aneuploidy, c-mitosis, etc. Single oral doses (4 -12 g/kg) of D. gossweileri stem bark extracts of 
produced acute toxicity in rats, but did not result in mortality or significant behavioural and 
biochemical changes. In subacute toxicological studies with both male and female rats, orally 
administered bark extract (48 hourly dosing of 500 mg/kg or 1000 g/kg for 4 weeks) did not cause 
any changes in biochemical or haematological parameters. There were no indicators of toxicity in 
terms of feeding or body weight alterations, with the exception of 1000 mg/kg dosed male rats 
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observed to have slightly decreased body weight. Morphological examination of various organs and 
fluctuations in their relative weights revealed no differences between control groups (treated with 
distilled water or maize oil) and treated rats (Ngouana et al., 2010). Moreover, no toxic effect was 
noticed in male and female albino Wistar rats treated per os with the crude stem bark extract at a dose 
up to 12 g/kg of body weight (Ngouana et al., 2011).  
 
3.4.  Correlation of traditional medicinal use with bioactivity of crude extracts and isolated 
compounds  
Traditional medicinal use of D. chevalieri, D. gerrardii, D. gossweileri, D. natalensis as well as D. 
roxburghii showed a clear correlation with significant bioactivities found in vivo and/or in vitro 
against malaria, cancers, pain, and rheumatism (table 3). Therefore, chemical and pharmacological 
investigation of other African traditional medicinal species is recommended for the following parts 
of plant which are preferrently applied for medicinal preparations. Among the 19 Drypetes species 
studied, only 5 were biologically tested according to the traditional uses of the plant. This may be due 
to the lack of appropriate equipment for biological tests or because the plants were studied separately 
by a chemist, a pharmacologist or a biologist. This is why the interdisciplinary approach (biologist, 
phytochemists and pharmacologist) should be followed, to conduct a comprehensive research work 
on any species. 
Table 3:  Correlation traditional medicinal use of plants from the family Putranjivaceae  with  
                bioactivities in vitro and in vivo 
Plant name Traditional medicinal use Bioactivity of compounds and 
extract related to the 
traditional use 
References 
Drypetes chevalieri Unspecified parts of the plant 
are used in Cameroon for the 
treatment of tumors  
putanjivadione 8 isolated from 
the stem was active against 
hepatocellular carcinoma cell 
line BEL7402, human lung 
cancer cell line A549 and 
leukemia cell line HL60.  
Dalziel and Hutchinson, 
1937; Bouquet and 
Debray, 1974;  Wansi et 
al., 2006, 2007; Chen et 
al., 2014 
Drypetes gerrardii Unspecified parts of the plant 
are used for the treatment of 
malaria among 'Chonyi' 
people in Kilifi District, 
Coast province, Kenya  
resinone 66, drypetenone D 92 
and E 93 showed significant in 
vitro antiplasmodial activity and 
not toxic against rat myoblast 
cell line L6. Drypetenone D 92 
not active in Plasmodium 
berghei mouse model 
Ng′ang′ a et al., 2011, 
2012;  Hata et al., 2014 
Drypetes gossweileri The bark is used in Western 
Africa for the treatment of 
pain 
Extract displayed significant 
analgesic activity in animal 
models, and was not toxic in 
animal model as well 
Bouquet, 1969;  Burkill, 
1985;  Muganza et al., 
2012;  Ngouana et al., 
2010, 2011;  Bomba et 
al., 2013 
Drypetes natalensis Unspecified parts of the plant 
are used for the treatment of 
malaria in Tanzania  
The stem bark and root extracts 
were antiplasmodial in vitro and 
not toxic against rat myoblast 
cell line L6  
Gessler et al., 1995; 
Malebo et al., 2009 
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Drypetes roxburghii A paste composed of the 
seeds is applied in India to 
the forehead for the 
treatment of pain  
The seed extract showed relief 
of pain in animal model; the 
seed extract was not toxic 
against Artemia salina 
Sudharshan et al., 2009; 
Kumar, 2012; Kadir et 
al., 2013;  Raghavendra 
et al., 2010 
Leaves and another parts are 
used in India in the treatment 
of rheumatism and 
inflammation  
The extract showed reduction of 
inflammation in animal models, 
however, the leaf extract 
displayed acute oral toxicity and 
induced mitosis-disruptive 
chromosomal changes in bone 
marrow cells 
Chopra et al., 1970b; 
Awasthy et al., 2000; 
Sudharshan et al., 2009; 
Reanmongkol et al., 
2009; Pandey and Tripati, 
2011; Kaushik et al., 
2012; Kumar, 2012;  
Rajahamsa et al., 2013 
 
4. Conclusions 
 
The genus Drypetes has been used in the Subsaharan African and Asian traditional medicines to treat 
a multitude of disorders, like microbial infections, malaria, inflammation, tumours, as well as for the 
treatment of wounds, headache, and urethral problems. Some Drypetes species are used to protect 
food against pests, as an aphrodisiac, a stimulant/depressant, a rodenticide and a fish poison, against 
insect bites, to induce conception and for general healing. From 19 Drypetes species, a total of 142 
different compounds belonging to more than 10 classes of natural compounds, including triterpenoids 
(76) (friedelane (35), oleanane (22), lupine (16) and hopane-type (3)), sesquiterpenoids (11), 
dinorditerpenoids (10), phenylpropanoid-phenylethanoid (9), lignans (8), steroids (7), flavonoids (6),  
xanthone (1), anthraquinone (1) as well as some thiocyanates (5) and other metabolites (8), had been 
isolated. Triterpenoids, especially the friedelane derivatives were the only class of compound isolated 
in all 19 species. 10 pimarane dinorditerpenoids were isolated from the species collected in Asia D. 
littoralis (Taiwan), D. perreticulata (China), and in Africa D. gerrardii (Kenya), D. gossweileri 
(Cameroon). These compounds with aromatic ring C were exclusively isolated from this genus and 
might turn out to be good candidates for chemotaxonomic markers. Several crude extracts of these 
plants, and isolated compounds displayed significant analgesic, anthelmintic, antidiabetic, anti-
emetic anti-inflammatory, antioxidant, antiparasitic, central nervous system depressant, cytotoxic, 
and insecticidal activities both in vitro and in vivo. But, concerning the safety of traditional medicines 
derived from Drypetes, it should be noted that some crude extracts showed significant toxicity in 
Artemia salina model and in female Wistar albino rat, in addition, some extracts induced mitosis-
disruptive chromosomal changes in the bone marrow cells of Swiss albino mice. Moreover, the 
flavonoid amentoflavone (128) reported from the extracts of genus Drypetes showed high toxicity 
against L-1-rat skeletal myoblast cells. Most of the Drypetes genus used in tradional medicine has 
never been investigated for their toxicity; therefore, doses given by the traditional healers might result 
in increased health problems or even death. As a consequence, traditional medicine from this genus 
should in future be applied with care. Further toxicological studies on the genus are urgently needed 
to improve their safety in traditional medicinal applications. Nevertheless, it is suggested that 
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dinorditerpenoids might play an important biologic role within the genus Drypetes. These compounds 
displayed very significant antimalarial activity in vitro against chloroquine-resistant African 
Plasmodium falciparum NF54 with IC50 of 0.9 μM, as well as significant cytotoxic activity against 
the leukemia cell line HL60 with IC50 of 1.95-1.37 µM. Further bioactivity testing of these 
compounds is recommended. Among the 19 Drypetes species, only D. chevalieri, D. gerrardii, D. 
gossweileri, D. natalensis as well as D. roxburghii showed a clear correlation with significant 
bioactivities found in vivo and/or in vitro against malaria, cancers, pain, and rheumatism. This may 
be due to the lack of appropriate equipment for biological tests in Africa and in Asia or because the 
plants were studied separately by a chemist, a pharmacologist or a biologist. It’s why the 
interdisciplinary approach is recommend (biologist, phytochemists and pharmacologist) to conduct a 
comprehensive bioassay-guided fractionation of not yet examined species.  
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